Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ADAMTS3 "ADAMTS-4, KIAA0366" ENSG00000156140 "ADAM metallopeptidase with thrombospondin type 1 motif 3" O15072 4 72280969-72569386 "Cancer-related genes, Predicted secreted proteins" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 13.7;Leydig cells: 18.4;Rod photoreceptor cells: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 12.6;AN3-CA: 7.3;HEL: 12.9;K-562: 11.0;SH-SY5Y: 6.6;U-2 OS: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021368, HPA021369" Uncertain Approved "Intermediate filaments" "Secreted to extracellular matrix" NA NA "Intermediate filaments" "HPA021368: AB_2670681, HPA021369: AB_2670682" "unprognostic (1.93e-1)" "unprognostic (3.47e-3)" "unprognostic (1.41e-1)" "unprognostic (1.05e-3)" "unprognostic (6.11e-2)" "unprognostic (2.60e-1)" "unprognostic (3.26e-3)" "unprognostic (1.60e-3)" "unprognostic (5.92e-4)" "unprognostic (3.11e-2)" "unprognostic (1.93e-1)" "unprognostic (2.60e-1)" "unprognostic (8.63e-3)" "unprognostic (1.65e-3)" "unprognostic (1.17e-1)" "unprognostic (2.72e-1)" "unprognostic (1.50e-4)" 5.3 2.6 3.3 4.4 5.6 2.1 7.8 0.3 4.6 4.4 2.3 1.1 1.9 0.5 9.6 14.4 1.0 7.5 1.9 2.8 1.3 0.9 4.7 2.7 3.1 2.0 0.7 2.2 7.5 1.0 12.4 1.1 8.2 2.2 2.6 1.1 3.9 1.4 3.4 0.8 1.5 0.9 4.6 1.8 1.9 1.6 5.6 1.3 0.6 4.4 0.8 1.0 2.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 7.3 0.1 0.3 0.1 0.6 2.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 4.6 0.0 1.8 0.0 1.6 12.9 1.0 0.0 0.2 0.0 0.0 1.7 0.1 0.6 0.1 3.1 0.0 0.0 11.0 0.0 0.0 0.0 1.1 0.0 2.0 0.0 3.8 0.0 2.5 0.0 4.3 0.0 0.5 6.6 0.0 0.5 0.2 1.4 0.1 0.1 0.1 5.4 8.1 0.0 0.6 0.0 0.0 0.0 1.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 5.6 0.3 4.6 1.3 0.9 0.7 2.2 2.2 1.3 0.0 4.3 0.0 1.0 0.5 0.8 0.8 0.0 0.0 2.3 1.8 13.7 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.2 1.6 0.7 1.1 0.0 0.0 0.0 0.0 2.5 0.0 1.3 18.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 4.2 0.2 11.9 0.0 0.7 1.0 0.4 0.0 0.0 0.0 0.0 0.0 ADCY5 AC5 ENSG00000173175 "Adenylate cyclase 5" O95622 3 123282296-123449758 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 69.9" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 56.0;Paneth cells: 59.6;Peritubular cells: 69.3;Sertoli cells: 64.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 18.0;RPMI-8226: 3.1;RPTEC TERT1: 6.5" "Region enriched" "Detected in many" 5 "basal ganglia: 347.3" "Region enriched" "Detected in all" 6 "basal ganglia: 205.1" "HPA017730, HPA077682" Uncertain Enhanced "Intermediate filaments" NA NA "Intermediate filaments" "HPA017730: AB_1844595, HPA077682: AB_2686851" "unprognostic (3.55e-2)" "unprognostic (1.01e-3)" "unprognostic (7.61e-3)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.48e-1)" "unprognostic (7.61e-2)" "unprognostic (2.49e-2)" "unprognostic (2.34e-1)" "unprognostic (7.27e-3)" "unprognostic (2.64e-2)" "prognostic favorable (7.46e-6)" "unprognostic (1.81e-2)" "unprognostic (5.65e-2)" "unprognostic (3.19e-2)" "unprognostic (5.97e-4)" 13.3 3.0 12.5 3.7 32.0 0.6 9.3 2.6 14.4 4.5 11.7 10.4 3.1 4.2 6.2 4.4 13.8 5.3 7.3 69.9 10.4 8.3 5.3 2.4 2.6 2.0 15.0 8.6 10.1 5.7 1.1 7.7 4.8 9.7 13.8 4.6 4.6 3.1 16.3 2.2 1.1 4.8 13.5 8.8 4.7 9.6 5.9 16.0 0.0 1.0 0.2 2.6 9.5 8.5 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.7 1.6 0.1 0.1 0.1 0.4 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.4 0.2 2.7 0.5 0.8 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 18.0 0.0 0.0 1.0 0.0 0.1 0.0 0.4 3.1 6.5 0.6 2.2 2.0 0.0 0.6 0.1 2.2 0.0 0.1 0.0 0.1 1.5 0.1 0.3 0.2 0.7 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 12.5 32.0 2.6 14.4 10.4 8.3 15.0 8.6 9.7 16.0 0.0 0.0 0.0 0.1 0.2 16.5 56.0 2.5 0.0 0.0 7.0 0.0 1.1 0.0 11.5 0.7 0.4 0.5 0.0 6.3 3.1 2.3 0.1 0.0 0.0 0.2 0.0 0.0 2.5 0.0 1.1 19.0 0.0 0.0 1.8 0.3 0.8 0.6 59.6 69.3 0.7 1.5 64.7 12.2 0.7 5.6 0.6 10.4 0.0 1.2 0.0 ANAPC4 APC4 ENSG00000053900 "Anaphase promoting complex subunit 4" Q9UJX5 4 25377213-25418498 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 65.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032519, HPA038395, HPA038396" Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "CAB032519: AB_2274023, HPA038395: AB_10794632, HPA038396: AB_10795356" "unprognostic (1.36e-1)" "unprognostic (9.15e-2)" "unprognostic (6.06e-3)" "prognostic favorable (5.73e-7)" "unprognostic (1.14e-1)" "prognostic favorable (1.95e-4)" "unprognostic (1.18e-3)" "unprognostic (5.44e-3)" "unprognostic (1.07e-1)" "unprognostic (6.11e-3)" "unprognostic (1.28e-1)" "unprognostic (8.86e-2)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.93e-1)" "unprognostic (1.15e-1)" "unprognostic (8.95e-2)" "prognostic favorable (1.12e-6)" 12.2 15.4 14.5 15.7 14.9 14.7 14.5 16.4 16.4 22.7 13.0 14.8 25.4 10.5 29.2 21.4 13.0 32.3 11.0 10.7 12.6 10.6 12.6 13.0 13.0 16.6 15.8 10.4 18.8 15.3 15.3 22.4 13.7 13.5 15.4 15.5 14.7 13.3 36.5 12.3 13.0 14.4 23.4 16.2 18.2 13.0 9.6 14.2 19.6 13.4 7.3 15.9 18.3 13.4 8.5 6.4 13.8 11.3 9.4 13.8 6.0 12.4 7.3 12.9 13.5 13.7 15.3 18.6 14.9 11.2 14.1 13.7 11.7 20.0 20.5 8.0 12.7 18.1 10.1 13.7 12.6 16.4 7.2 10.6 19.9 13.1 10.9 9.2 15.4 16.3 11.8 9.5 12.5 7.6 10.1 12.2 18.2 28.6 6.2 17.9 9.7 19.8 25.2 18.0 11.0 9.2 14.3 21.8 15.2 11.9 13.6 14.6 8.7 11.1 6.7 9.2 13.9 9.9 16.7 12.4 12.2 7.7 9.3 17.1 8.3 14.4 19.6 13.1 22.1 11.4 1.8 7.4 13.8 10.1 8.7 13.8 8.5 9.1 11.8 6.4 7.0 8.3 10.3 3.0 9.4 11.3 4.1 11.0 6.0 14.5 14.9 16.4 16.4 12.6 10.6 15.8 10.4 13.5 14.2 8.9 12.6 4.2 15.2 11.4 12.1 11.5 12.7 65.6 18.2 7.0 9.8 46.1 5.0 8.6 3.3 9.0 7.4 0.0 10.5 10.3 11.6 5.8 24.3 6.4 15.4 20.6 12.1 14.1 14.5 2.5 9.5 11.0 16.9 11.8 7.7 11.6 7.3 3.5 14.2 4.5 12.9 19.4 9.9 11.4 14.0 8.2 19.9 17.5 11.3 6.5 APOBEC3C "APOBEC1L, ARDC2, ARDC4, ARP5, bK150C2.3, PBI" ENSG00000244509 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3C" Q9NRW3 22 39014083-39020352 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 114.8" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB033048, HPA071523" Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "CAB033048: AB_2057401, HPA071523: AB_2686409" "unprognostic (1.79e-3)" "prognostic favorable (1.08e-5)" "unprognostic (4.32e-3)" "unprognostic (3.20e-3)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (5.18e-2)" "unprognostic (2.55e-1)" "unprognostic (1.10e-1)" "unprognostic (1.08e-3)" "unprognostic (7.40e-2)" "unprognostic (4.10e-2)" "prognostic unfavorable (8.91e-10)" "unprognostic (5.92e-2)" "unprognostic (1.11e-1)" "unprognostic (4.10e-1)" "unprognostic (3.52e-3)" 13.3 28.0 2.3 15.6 3.4 9.2 8.0 1.1 2.0 21.4 13.1 4.2 27.5 4.5 18.2 23.5 19.6 20.9 13.8 13.0 2.2 2.0 6.3 4.5 11.7 20.9 3.3 2.0 26.4 5.3 0.7 3.3 7.7 3.2 20.7 12.0 12.9 12.3 114.8 3.4 6.9 11.8 17.2 4.2 32.2 8.1 45.6 2.4 16.2 8.7 17.0 45.5 21.8 12.7 48.1 19.7 49.3 42.6 35.2 61.3 26.2 10.6 10.5 1.8 20.8 11.7 24.3 9.1 7.9 15.4 11.6 15.6 10.0 12.2 31.8 5.3 15.5 7.4 11.0 1.8 33.3 11.4 12.0 9.0 30.6 0.5 8.3 12.7 19.9 30.8 26.3 19.4 15.2 3.8 5.8 6.5 0.2 18.7 40.6 23.3 0.1 7.9 10.8 2.8 0.1 23.2 13.9 4.8 26.4 7.7 14.2 0.5 1.4 11.4 0.0 5.7 4.8 0.1 7.3 3.3 6.3 10.8 3.3 3.4 11.0 11.3 2.6 19.3 12.9 16.3 13.6 20.3 49.3 61.3 40.2 42.2 44.6 33.6 54.6 19.7 48.1 11.5 41.1 2.7 35.2 42.6 16.7 30.5 26.2 2.3 3.4 1.1 2.0 2.2 2.0 3.3 2.0 3.2 2.4 3.0 21.0 91.0 37.0 22.3 0.0 17.3 28.1 13.4 12.5 7.0 0.0 3.2 0.0 25.1 1.9 8.9 11.9 116.8 1.2 1.5 27.8 15.7 55.4 0.8 53.0 0.0 25.3 28.8 42.1 4.1 53.5 30.8 42.2 70.3 16.2 24.7 7.9 12.7 35.7 1.0 0.2 25.8 28.8 1.6 1.5 14.3 1.6 91.6 16.1 44.2 C11orf95 MGC3032 ENSG00000188070 "Chromosome 11 open reading frame 95" C9JLR9 11 63759892-63768775 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 15.3;Leydig cells: 17.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045002 Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA045002: AB_2679179" "unprognostic (4.23e-3)" "unprognostic (7.24e-3)" "unprognostic (6.47e-2)" "unprognostic (9.01e-3)" "unprognostic (7.54e-2)" "unprognostic (3.89e-1)" "unprognostic (8.94e-2)" "unprognostic (3.67e-1)" "unprognostic (1.03e-1)" "unprognostic (6.00e-2)" "unprognostic (8.01e-3)" "unprognostic (2.89e-1)" "unprognostic (1.52e-3)" "unprognostic (1.85e-2)" "unprognostic (6.60e-2)" "unprognostic (5.68e-2)" "unprognostic (1.31e-3)" 7.3 4.7 6.0 3.0 6.3 0.6 9.3 3.4 7.9 11.1 4.3 1.9 7.2 2.1 10.5 4.6 4.2 6.8 7.0 5.2 4.3 6.3 3.8 3.5 3.4 0.1 3.7 14.2 5.3 4.7 1.6 7.3 2.5 5.9 2.0 3.3 5.6 7.4 4.4 1.2 1.9 8.8 1.5 3.5 1.9 3.8 1.0 4.9 6.6 3.4 3.2 5.0 15.1 0.6 0.7 1.0 1.5 2.3 0.9 0.3 2.1 2.9 22.3 7.4 11.6 13.5 3.5 8.2 5.9 3.9 2.7 7.1 1.4 6.9 12.0 7.8 2.9 4.9 9.6 3.3 4.4 6.7 6.5 4.6 4.8 3.2 4.1 2.2 3.8 10.0 1.1 6.3 2.1 12.8 8.6 6.3 5.8 3.1 6.2 2.8 8.2 11.4 10.4 1.3 8.5 19.6 4.2 2.2 5.6 2.7 9.4 19.9 3.9 4.2 10.9 9.5 5.9 5.4 13.4 7.9 7.4 10.1 4.7 2.9 3.7 8.5 2.1 5.7 4.0 0.0 0.1 0.0 0.8 1.5 0.4 0.0 0.2 0.9 0.0 0.6 0.4 0.6 1.0 2.3 0.3 0.7 0.0 0.3 0.0 4.0 1.4 1.0 4.5 4.1 6.0 15.3 1.4 1.2 0.0 0.0 5.4 3.3 2.4 0.1 5.1 0.6 0.0 1.8 0.4 9.9 1.3 1.1 6.8 1.3 6.4 4.7 10.4 2.1 1.2 17.0 2.1 3.3 5.4 3.2 10.2 2.4 0.0 7.4 3.3 2.9 12.9 7.8 0.4 3.8 3.0 1.3 0.0 2.1 0.9 C12orf54 MGC35033 ENSG00000177627 "Chromosome 12 open reading frame 54" Q6X4T0 12 48482503-48496512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "testis: 34.8" "Cell type enriched" "Detected in many" 5 "Late spermatids: 2100.5" "Group enriched" "Detected in some" 9 "cervical cancer: 2.9;head and neck cancer: 2.1;lung cancer: 1.6;urothelial cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 2.8;HBEC3-KT: 9.4;hTCEpi: 2.6;hTERT-HME1: 5.6" HPA073090 Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA073090: " "unprognostic (2.59e-3)" "unprognostic (5.49e-2)" "unprognostic (7.94e-3)" "unprognostic (2.60e-2)" "unprognostic (2.48e-2)" "unprognostic (8.99e-2)" "unprognostic (5.96e-2)" "unprognostic (1.62e-1)" "unprognostic (8.01e-2)" "unprognostic (1.36e-4)" "unprognostic (2.37e-1)" "unprognostic (5.06e-3)" "unprognostic (7.53e-2)" "unprognostic (1.34e-1)" "unprognostic (1.97e-1)" "unprognostic (1.92e-1)" 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.6 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.0 34.8 0.1 0.1 0.1 0.1 0.9 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 9.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.6 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.2 0.1 0.3 0.1 0.1 0.1 0.0 1.6 0.0 22.3 4.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.1 444.4 0.1 0.0 0.0 0.0 0.1 0.4 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2100.5 10.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 12.4 0.2 0.0 6.5 1.4 12.9 6.4 1.9 0.0 0.0 0.0 8.4 C19orf25 FLJ36666 ENSG00000119559 "Chromosome 19 open reading frame 25" Q9UFG5 19 1461143-1479556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050270, HPA067491" Approved Approved "Intermediate filaments" No No "Intermediate filaments" "HPA050270: AB_2681069, HPA067491: AB_2685849" "unprognostic (5.82e-2)" "unprognostic (3.87e-2)" "unprognostic (6.51e-2)" "prognostic favorable (1.08e-4)" "unprognostic (1.74e-1)" "unprognostic (2.14e-3)" "prognostic unfavorable (3.81e-4)" "unprognostic (1.10e-2)" "unprognostic (1.36e-1)" "unprognostic (2.49e-2)" "prognostic favorable (1.21e-4)" "unprognostic (5.35e-2)" "prognostic favorable (9.20e-8)" "unprognostic (3.50e-3)" "unprognostic (8.01e-2)" "unprognostic (1.82e-1)" "unprognostic (1.91e-3)" 12.1 17.9 25.8 14.2 22.1 10.4 11.2 26.4 22.6 12.7 15.7 19.0 17.7 23.2 17.2 12.5 12.1 17.6 12.5 17.2 24.5 21.8 17.9 16.8 13.0 19.9 23.4 15.6 16.4 27.0 10.4 18.2 15.4 15.3 15.3 8.2 16.5 27.0 13.9 11.7 13.7 22.2 14.0 23.0 16.5 16.8 17.6 17.2 17.3 24.1 7.4 14.9 12.6 18.0 28.2 28.6 34.1 20.2 17.1 31.2 23.0 13.1 10.2 6.4 10.1 6.2 5.7 12.7 13.0 9.1 14.2 13.1 14.7 6.8 7.6 10.3 7.0 6.6 16.3 9.7 8.3 3.3 23.5 14.6 9.2 6.0 17.1 13.5 14.5 18.3 5.3 18.9 5.9 9.5 10.0 7.3 16.2 23.8 18.0 8.9 7.4 13.6 12.1 20.3 8.2 16.6 22.4 8.9 19.4 9.8 9.0 10.8 14.7 9.7 12.5 15.4 3.4 18.3 17.1 8.9 10.9 12.4 22.0 12.4 25.6 13.8 12.6 11.3 14.8 19.4 26.5 20.2 34.1 27.4 19.7 22.2 22.1 25.2 23.4 14.4 28.2 26.1 20.9 32.1 17.1 15.7 28.6 31.2 23.0 25.8 22.1 26.4 22.6 24.5 21.8 23.4 15.6 15.3 17.2 14.9 8.3 41.0 27.9 17.1 58.8 8.9 20.4 8.1 9.1 48.8 60.9 37.2 41.4 32.8 3.5 20.3 69.8 0.0 40.0 27.2 22.8 28.7 11.5 16.6 31.1 92.2 48.6 25.2 22.2 5.2 24.5 24.1 23.6 59.5 25.9 47.3 39.9 52.6 20.5 23.9 70.3 45.3 22.8 28.8 32.4 17.2 44.3 48.4 26.4 30.6 C1orf141 ENSG00000203963 "Chromosome 1 open reading frame 141" Q5JVX7 1 67092165-67231853 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 14.9;fallopian tube: 12.8;testis: 18.7" "Group enriched" "Detected in some" 4 "Ciliated cells: 84.3;Early spermatids: 83.3;Late spermatids: 78.9;Muller glia cells: 34.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "pons and medulla: 14.9" "Group enriched" "Detected in some" 5 "basophil: 2.5;neutrophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.5" "Cell line enriched" "Detected in single" 37 "HEL: 18.1" "Low region specificity" "Detected in all" HPA035316 Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA035316: AB_10600886" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (1.01e-1)" "unprognostic (2.20e-2)" 0.0 0.0 1.1 0.0 2.6 0.0 0.0 0.1 1.3 0.3 0.1 1.9 0.0 0.0 0.1 1.1 0.0 12.8 0.2 0.0 2.6 1.8 0.1 0.1 2.0 0.1 0.3 0.7 1.8 0.0 0.0 1.0 0.0 14.9 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.2 18.7 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 2.5 0.1 0.4 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 18.1 0.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.4 0.0 0.1 0.0 0.5 1.1 2.6 0.1 1.3 2.6 1.8 0.3 0.7 14.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 84.3 15.9 0.0 0.0 0.0 0.0 0.0 83.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 78.9 1.7 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.7 0.0 1.3 0.0 0.0 6.0 0.7 0.0 0.1 0.0 0.0 0.0 CDC42BPA "FLJ23347, KIAA0451, MRCK, MRCKA, PK428" ENSG00000143776 "CDC42 binding protein kinase alpha" Q5VT25 1 226989865-227318474 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Horizontal cells: 211.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB070414, HPA071252" Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "CAB070414: AB_11156796, HPA071252: AB_2686374" "unprognostic (3.67e-3)" "unprognostic (1.45e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-2)" "unprognostic (3.04e-1)" "unprognostic (5.90e-2)" "unprognostic (7.89e-2)" "unprognostic (2.27e-1)" "unprognostic (1.46e-1)" "unprognostic (3.93e-1)" "unprognostic (4.88e-2)" "unprognostic (2.87e-2)" "unprognostic (7.73e-3)" "unprognostic (1.35e-1)" "unprognostic (1.70e-1)" "unprognostic (9.79e-2)" "unprognostic (1.21e-2)" 17.2 15.2 19.1 8.6 21.1 3.9 14.0 29.2 20.4 21.1 19.3 16.4 13.1 16.9 15.8 9.9 12.3 12.9 16.6 14.1 21.7 17.7 20.8 17.0 11.7 3.5 20.0 16.3 17.4 15.1 29.3 29.6 14.8 19.3 21.1 12.4 11.0 8.4 18.5 11.9 7.6 17.2 27.6 16.6 8.8 25.2 26.7 19.9 0.7 9.8 7.3 2.5 23.4 23.1 0.1 0.7 2.0 0.1 0.0 0.1 0.0 9.5 9.0 9.7 4.5 9.7 12.0 3.4 11.0 15.6 7.6 8.0 7.3 21.8 0.0 11.8 18.2 5.7 4.4 7.1 6.1 9.3 0.0 5.7 7.4 10.8 2.8 11.0 5.9 3.3 8.4 7.9 12.3 12.4 9.5 25.3 5.9 18.7 0.0 12.3 2.6 0.1 1.0 7.9 12.4 8.7 0.0 16.3 0.0 12.2 18.5 7.0 10.2 18.6 7.8 10.9 6.2 10.1 0.3 25.5 13.9 7.3 15.9 14.5 0.0 0.0 0.0 18.5 0.0 18.6 2.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 19.1 21.1 29.2 20.4 21.7 17.7 20.0 16.3 19.3 19.9 38.7 29.4 1.4 19.9 10.4 96.7 50.6 25.5 21.4 35.2 41.8 111.9 5.2 11.6 22.3 90.9 47.3 45.2 23.3 35.4 6.1 27.8 25.0 6.9 24.5 3.2 211.4 25.3 42.4 7.1 98.3 40.9 6.8 15.1 9.0 24.1 34.1 46.5 54.5 80.2 32.9 64.0 77.6 45.3 40.8 51.3 6.9 1.1 1.3 26.4 26.8 DES "CMD1I, CSM1, CSM2" ENSG00000175084 Desmin P17661 2 219418377-219426739 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease mutation, Limb-girdle muscular dystrophy, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 531.0;skeletal muscle: 600.8;smooth muscle: 439.9" "Cell type enriched" "Detected in many" 12 "Cardiomyocytes: 2379.6" "Cancer enhanced" "Detected in all" "prostate cancer: 562.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 2.7;intermediate monocyte: 1.9;non-classical monocyte: 1.4" "Lineage enriched" "Detected in single" 6 "monocytes: 2.7" "Cell line enhanced" "Detected in some" "HSkMC: 18.1;LHCN-M2: 36.0;NB-4: 9.4;RH-30: 83.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 45.7" "CAB000034, HPA018803" Enhanced Supported "Intermediate filaments" NA NA 1300000 "Intermediate filaments" "CAB000034: , HPA018803: AB_1847616" "unprognostic (1.75e-1)" "unprognostic (1.95e-3)" "unprognostic (3.43e-2)" "unprognostic (8.76e-2)" "unprognostic (7.75e-3)" "unprognostic (6.61e-3)" "unprognostic (1.55e-1)" "unprognostic (2.72e-2)" "unprognostic (4.67e-1)" "unprognostic (3.84e-2)" "unprognostic (2.57e-1)" "unprognostic (7.43e-2)" "prognostic unfavorable (5.08e-4)" "unprognostic (3.49e-2)" "unprognostic (1.34e-1)" "unprognostic (1.22e-1)" "unprognostic (9.25e-3)" 9.1 2.5 0.1 35.1 0.2 0.1 1.9 0.1 0.3 41.3 238.3 0.4 69.1 12.6 95.6 80.2 209.7 33.0 149.8 531.0 0.1 0.1 2.1 0.3 4.8 3.0 0.3 0.8 20.3 0.7 0.0 0.1 2.4 0.8 101.0 11.2 3.8 11.9 104.2 600.8 4.2 43.2 439.9 0.3 0.6 72.6 10.9 0.0 0.0 9.4 161.2 12.5 343.7 34.4 0.0 0.2 0.4 2.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.3 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 36.0 0.0 0.0 9.4 0.1 0.0 0.0 0.0 83.8 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.7 0.1 0.2 0.1 0.3 0.1 0.1 0.3 0.8 0.8 0.0 0.0 0.0 0.0 2.4 3.7 0.0 2379.6 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 70.8 4.5 0.0 0.0 0.0 3.6 31.7 3.6 0.0 0.0 4.8 0.0 0.0 0.6 0.0 43.3 26.7 0.4 11.8 0.0 0.5 0.0 0.8 0.0 47.4 0.0 0.0 45.3 204.9 1.8 1.7 8.5 7.1 0.0 0.0 0.4 DISC1 ENSG00000162946 "Disrupted in schizophrenia 1" Q9NRI5 1 231626815-232041272 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Developmental protein" Schizophrenia "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 105.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "THP-1: 12.4;TIME: 9.7;WM-115: 9.9" "Low region specificity" "Detected in all" HPA048911 Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA048911: AB_2732549" "unprognostic (1.08e-1)" "unprognostic (1.40e-1)" "unprognostic (1.58e-1)" "unprognostic (2.98e-1)" "unprognostic (2.57e-2)" "unprognostic (3.36e-2)" "unprognostic (6.69e-3)" "unprognostic (1.41e-1)" "unprognostic (9.49e-2)" "unprognostic (1.71e-1)" "unprognostic (8.89e-2)" "unprognostic (9.53e-2)" "unprognostic (1.31e-4)" "unprognostic (1.74e-2)" "unprognostic (2.02e-1)" "unprognostic (5.94e-2)" "unprognostic (1.94e-1)" 5.3 3.3 9.1 6.4 10.6 5.3 7.6 2.5 7.6 4.9 3.1 11.6 0.0 2.6 4.2 1.6 3.1 2.9 5.6 19.2 9.2 5.9 2.7 3.1 3.9 11.3 10.5 4.8 9.6 2.1 2.7 2.8 14.3 9.2 3.9 2.9 13.1 4.0 2.4 3.2 2.9 3.1 3.4 10.2 6.1 2.4 2.2 9.3 4.2 4.1 2.5 3.9 4.5 7.2 0.5 3.3 2.6 2.9 0.7 1.6 0.7 0.0 0.5 4.5 0.1 0.1 0.4 3.3 1.7 4.1 4.8 4.0 1.6 1.0 0.1 5.4 1.5 1.1 0.0 0.4 0.1 4.2 2.8 1.9 2.4 0.4 4.4 0.6 4.0 6.0 2.5 0.8 1.5 1.3 3.2 4.2 3.1 0.0 1.8 5.2 0.4 1.1 6.1 2.3 0.0 1.7 3.0 1.3 0.5 0.2 0.0 0.8 2.5 1.6 0.0 2.7 1.2 0.0 12.4 9.7 2.5 2.6 1.2 1.0 1.1 0.8 0.0 1.9 6.2 9.9 0.3 2.7 0.1 0.9 2.9 0.5 0.1 1.4 0.3 3.3 0.5 1.6 0.5 2.6 0.7 1.2 1.9 0.5 0.7 9.1 10.6 2.5 6.3 9.2 5.9 10.5 4.8 9.2 9.3 0.0 1.4 0.0 0.5 0.8 10.7 4.6 0.0 1.4 1.2 3.5 7.9 6.0 0.0 0.6 12.9 5.3 0.0 0.0 1.0 0.6 3.3 0.4 6.9 0.0 9.3 0.0 0.0 9.8 13.5 17.3 0.9 8.9 3.3 0.0 0.0 2.5 1.4 0.0 1.4 0.0 105.2 0.0 1.3 0.4 1.1 1.0 2.1 3.1 0.2 0.5 EPPK1 EPIPL1 ENSG00000261150 "Epiplakin 1" 8 143857324-143878464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 14.8;skin 1: 14.1;smooth muscle: 15.7" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 121.8;Suprabasal keratinocytes: 239.8" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.1" "Lineage enriched" "Detected in single" 22 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "BEWO: 11.1;EFO-21: 10.4;HaCaT: 10.3;HeLa: 17.3;MCF7: 14.9;SK-BR-3: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA066808, HPA067357, HPA069333" Approved Enhanced "Intermediate filaments" NA NA "Intermediate filaments" "HPA066808: AB_2685726, HPA067357: AB_2685826, HPA069333: AB_2686123" "unprognostic (1.42e-1)" "unprognostic (9.30e-2)" "unprognostic (5.89e-2)" "prognostic unfavorable (5.52e-5)" "unprognostic (2.85e-2)" "unprognostic (5.86e-3)" "unprognostic (4.90e-2)" "unprognostic (8.73e-2)" "unprognostic (9.60e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.35e-1)" "unprognostic (1.97e-3)" "unprognostic (5.94e-3)" "unprognostic (4.35e-1)" "unprognostic (3.68e-3)" "unprognostic (5.08e-3)" 0.0 0.0 0.0 3.0 0.0 0.0 1.1 0.7 0.0 0.4 7.8 0.0 7.2 3.1 3.4 2.4 6.0 1.4 2.3 0.0 0.0 0.8 0.0 4.2 0.9 0.0 0.0 1.0 1.9 0.6 0.0 2.8 0.5 2.9 0.8 0.0 14.8 4.9 0.1 14.1 12.1 15.7 0.1 1.5 1.2 2.3 0.0 0.0 0.0 7.2 4.3 4.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 5.8 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 5.6 0.4 0.0 10.4 0.0 0.0 10.3 1.1 0.1 0.0 0.0 2.6 0.0 17.3 3.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.9 0.0 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 3.7 1.8 0.0 1.6 7.1 0.0 0.9 5.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 1.0 0.2 0.0 0.0 2.1 0.8 0.0 0.0 0.0 0.0 0.2 0.0 17.9 8.6 0.0 14.7 121.8 0.8 15.4 17.8 9.4 2.3 14.0 0.0 1.6 0.0 10.2 0.3 1.1 29.4 0.0 12.8 0.1 1.9 5.7 0.0 3.0 0.3 0.0 5.8 0.6 0.0 0.0 0.0 0.6 15.1 0.0 11.2 0.5 21.7 23.0 0.0 3.5 0.1 0.0 4.1 1.6 0.4 239.8 5.1 0.0 21.5 36.3 FAIM2 "KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2" ENSG00000135472 "Fas apoptotic inhibitory molecule 2" Q9BWQ8 12 49866896-49904217 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 138.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 136.4;Early spermatids: 135.6;Horizontal cells: 219.3" "Cancer enriched" "Detected in many" 8 "glioma: 21.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 1.7;T-reg: 6.2" "Lineage enriched" "Detected in single" 9 "T-cells: 6.2" "Cell line enhanced" "Detected in some" "HHSteC: 9.1;OE19: 11.7;SH-SY5Y: 4.9;U-87 MG: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018790, HPA048800" Enhanced Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA018790: AB_1852822, HPA048800: AB_2680526" "unprognostic (1.74e-1)" "unprognostic (5.98e-4)" "unprognostic (2.22e-1)" "unprognostic (9.75e-3)" "unprognostic (3.36e-2)" "unprognostic (2.61e-4)" "unprognostic (2.62e-1)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (1.75e-2)" "unprognostic (5.66e-2)" "unprognostic (1.30e-2)" "unprognostic (3.28e-6)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (2.47e-1)" "unprognostic (6.78e-4)" 3.9 27.2 35.6 4.1 57.5 1.4 2.5 42.4 138.5 3.2 4.7 29.1 0.2 2.7 4.2 6.4 3.9 5.8 7.5 7.4 38.8 51.0 2.0 1.5 2.5 3.5 35.9 33.7 2.6 2.8 14.7 7.8 1.5 65.6 8.8 3.5 3.9 3.0 7.1 2.0 1.8 4.0 8.7 36.9 2.5 2.6 12.1 20.5 0.0 1.7 0.0 3.1 4.7 2.0 0.0 0.0 0.0 0.4 0.6 6.2 0.2 0.0 0.3 0.4 0.5 2.0 1.3 0.1 0.5 2.6 0.5 0.3 0.3 0.0 0.0 0.1 3.6 0.2 0.2 1.2 0.0 0.3 0.0 0.0 2.0 0.0 0.0 9.1 0.1 0.0 0.8 0.2 1.9 0.0 0.0 0.0 0.2 1.1 0.3 0.5 0.0 0.1 0.0 0.0 11.7 0.0 0.0 0.1 0.0 0.0 0.0 3.2 4.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 28.4 0.0 0.2 0.0 0.1 0.0 1.7 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 6.2 0.2 35.6 57.5 42.4 99.5 38.8 51.0 35.9 33.7 65.6 20.5 0.0 0.0 0.0 0.1 0.2 136.4 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 135.6 0.0 0.0 0.0 0.2 0.0 1.4 0.6 26.4 0.0 0.4 219.3 0.0 0.0 0.0 31.4 4.6 0.0 0.0 0.0 2.0 34.2 0.1 0.0 4.9 0.1 14.5 0.0 0.9 1.2 2.1 0.3 0.1 0.0 0.2 0.1 FAM174B "LOC400451, MGC102891" ENSG00000185442 "Family with sequence similarity 174 member B" Q3ZCQ3 15 92617443-92809884 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 57.6" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 98.3;Mucus-secreting cells: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Group enriched" "Detected in many" 7 "dendritic cells: 4.5;granulocytes: 3.7;T-cells: 10.9" "Cell line enhanced" "Detected in many" "CACO-2: 21.3;MCF7: 25.6;OE19: 21.5;RPMI-8226: 30.0;RT4: 63.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015306 Approved Approved "Intermediate filaments" No No "Intermediate filaments" "HPA015306: AB_2669182" "unprognostic (3.00e-3)" "unprognostic (1.80e-1)" "unprognostic (1.50e-1)" "prognostic favorable (9.03e-5)" "unprognostic (4.68e-2)" "unprognostic (1.63e-1)" "unprognostic (8.35e-2)" "unprognostic (8.23e-3)" "unprognostic (7.67e-3)" "unprognostic (5.05e-3)" "unprognostic (6.60e-2)" "unprognostic (1.33e-1)" "unprognostic (4.67e-2)" "unprognostic (2.01e-1)" "unprognostic (6.64e-2)" "unprognostic (1.61e-2)" "unprognostic (2.35e-2)" 6.1 3.5 5.9 3.3 6.3 0.7 17.9 3.9 8.6 10.9 6.2 2.9 21.5 3.6 5.1 4.9 5.2 14.6 6.4 4.2 7.4 8.3 3.3 4.0 16.3 5.5 6.5 6.2 10.2 57.6 2.5 15.9 4.6 6.7 19.4 9.2 7.7 47.7 10.8 16.3 4.9 5.0 4.6 4.9 3.2 17.3 9.7 3.6 4.2 28.9 3.9 4.8 24.4 15.3 0.4 4.5 3.7 0.9 0.7 10.9 0.7 0.0 3.6 2.3 0.7 0.0 0.0 0.3 1.3 6.3 0.0 0.0 21.3 2.4 0.3 6.1 0.1 1.7 0.1 4.0 0.1 0.0 0.1 1.8 0.2 0.4 0.2 0.4 0.3 0.9 0.3 0.1 0.0 0.0 0.1 3.0 2.0 0.3 15.8 3.5 25.6 0.7 0.0 11.5 21.5 0.0 2.4 6.6 30.0 1.5 63.4 1.4 1.1 1.8 12.2 3.9 7.0 9.8 2.2 0.0 0.0 0.5 0.1 2.9 0.5 4.7 0.7 0.0 0.2 1.5 1.1 0.8 0.9 0.2 0.9 0.4 0.4 2.5 0.0 0.6 0.3 2.8 3.3 3.7 0.7 0.0 4.5 10.9 0.7 5.9 6.3 3.9 8.6 7.4 8.3 6.5 6.2 6.7 3.6 98.3 20.3 0.0 14.7 2.1 5.3 4.1 10.2 14.7 18.2 7.0 7.9 1.1 6.6 4.4 19.8 5.8 2.3 0.0 12.4 15.9 4.1 29.2 18.4 5.8 4.2 11.1 40.5 30.7 4.3 39.0 5.5 1.8 11.8 0.0 61.2 3.5 17.4 0.0 1.8 1.1 2.7 0.0 5.3 1.0 3.4 2.6 0.6 2.1 4.7 23.7 FAM231C ENSG00000268674 "Family with sequence similarity 231 member C" "P0DMU3, P0DMU4, P0DMU5" Unmapped 35407-35916 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "blood: 1.6;brain: 5.6;parathyroid gland: 3.2;testis: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.1;U-698: 1.3" "HPA043267, HPA043292, HPA077864" Uncertain Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA043267: , HPA043292: , HPA077864: AB_2686862" 0.0 0.3 0.1 0.0 0.1 0.1 0.0 5.6 0.3 0.1 0.3 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.1 3.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GFAP FLJ45472 ENSG00000131095 "Glial fibrillary acidic protein" P14136 17 44903161-44916937 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 61 "brain: 595.5" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 48.9" "Cancer enriched" "Detected in some" 368 "glioma: 2468.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.8" "Group enriched" "Detected in many" 5 "granulocytes: 9.8;NK-cells: 2.9" "Cell line enhanced" "Detected in many" "U-87 MG: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000039, HPA056030, HPA063513" Enhanced Supported Supported "Intermediate filaments" No No 220000000 "Intermediate filaments" "CAB000039: AB_10013382, HPA056030: AB_2683015, HPA063513: AB_2685027" "unprognostic (1.79e-2)" "unprognostic (2.74e-1)" "unprognostic (9.83e-2)" "unprognostic (2.12e-5)" "unprognostic (4.08e-1)" "unprognostic (5.09e-1)" "unprognostic (1.26e-1)" "unprognostic (6.53e-2)" "unprognostic (6.57e-3)" "unprognostic (7.35e-2)" "unprognostic (5.86e-2)" "unprognostic (1.24e-1)" "unprognostic (7.63e-2)" "unprognostic (2.75e-5)" "unprognostic (1.49e-1)" "unprognostic (1.66e-1)" "unprognostic (1.64e-1)" 3.0 2.9 122.2 3.2 105.4 5.8 3.0 33.9 595.5 2.7 3.0 171.0 0.0 2.8 2.9 3.0 3.6 3.2 3.1 4.0 143.0 175.1 3.0 2.8 3.0 3.1 227.0 67.3 3.0 3.0 3.4 1.3 2.8 212.7 3.0 2.9 0.0 3.1 2.9 3.2 3.3 2.8 2.9 482.0 3.0 3.0 2.9 119.0 0.0 3.0 0.0 2.9 3.4 0.0 1.1 0.8 9.8 1.2 2.9 0.8 0.3 1.7 1.1 2.0 3.8 0.0 0.8 0.5 1.7 2.1 2.5 2.1 2.2 2.5 3.5 3.2 0.9 1.4 4.3 2.2 0.7 3.0 4.3 1.9 2.9 2.9 1.5 0.1 0.8 4.3 0.2 1.3 1.7 0.0 2.6 0.0 3.7 1.3 8.5 0.6 2.2 3.0 4.2 2.8 0.2 5.3 1.2 1.3 2.8 1.1 1.5 2.7 3.0 0.5 3.5 0.3 1.7 2.3 2.2 1.2 2.1 1.6 1.9 2.6 1.2 2.3 2.8 9.6 3.5 3.4 1.9 1.2 0.5 0.5 1.1 0.4 0.4 0.5 0.7 0.3 1.1 0.6 0.8 9.8 2.9 0.7 0.8 0.4 0.3 122.2 105.4 33.9 69.4 143.0 175.1 227.0 67.3 212.7 119.0 0.0 0.0 0.0 0.0 0.0 0.7 4.2 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 KBTBD11 "KIAA0711, KLHDC7C" ENSG00000176595 "Kelch repeat and BTB domain containing 11" O94819 8 1973878-2006936 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.4" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 33.4;Enterocytes: 28.4;Rod photoreceptor cells: 29.5" "Cancer enhanced" "Detected in many" "renal cancer: 14.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 4.6" "Group enriched" "Detected in many" 4 "granulocytes: 4.6;monocytes: 1.4" "Cell line enhanced" "Detected in some" "HDLM-2: 10.4;NB-4: 7.5;SCLC-21H: 9.1;THP-1: 14.7;U-937: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051159 Uncertain Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA051159: AB_2681367" "unprognostic (1.19e-1)" "unprognostic (2.27e-1)" "unprognostic (1.20e-3)" "unprognostic (2.70e-2)" "unprognostic (2.03e-1)" "unprognostic (6.84e-2)" "unprognostic (2.76e-4)" "unprognostic (2.50e-2)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.75e-2)" "unprognostic (9.53e-2)" "unprognostic (3.52e-2)" "unprognostic (1.75e-1)" "unprognostic (1.04e-2)" 3.2 6.8 17.6 2.6 17.7 8.7 1.8 16.3 22.4 4.5 8.2 10.9 0.0 10.9 1.6 1.7 1.7 3.8 3.8 2.1 16.1 10.8 13.9 6.7 2.3 3.1 13.2 16.7 1.9 3.2 5.1 2.0 0.8 11.4 5.0 6.6 3.1 2.1 2.9 1.8 1.0 12.7 1.7 12.4 6.4 1.9 1.6 9.3 4.7 2.4 0.0 2.0 1.4 0.7 0.0 0.4 4.6 1.4 0.0 0.6 0.4 1.5 1.0 4.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.9 0.4 0.1 0.4 0.1 0.0 2.1 0.0 0.0 10.4 1.2 0.0 0.0 0.0 1.0 4.5 0.2 0.2 0.0 0.0 0.0 0.7 0.0 4.0 0.0 0.0 2.1 0.8 4.6 7.5 1.0 1.6 0.0 1.3 0.0 0.0 2.2 0.3 9.1 4.6 0.0 0.0 0.1 0.4 0.1 14.7 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.1 20.9 0.8 0.7 1.4 4.6 0.0 0.6 0.2 0.0 0.2 0.1 0.4 0.0 0.6 0.3 0.9 0.0 0.3 0.0 0.5 0.4 17.6 17.7 16.3 21.9 16.1 10.8 13.2 16.7 11.4 9.3 0.0 7.2 0.5 0.4 0.9 21.8 4.5 10.2 2.7 0.0 12.2 33.4 0.0 21.6 1.6 0.6 4.1 28.4 0.0 3.3 0.1 1.1 2.7 0.0 10.6 3.3 19.1 5.8 4.9 9.5 0.0 4.6 2.1 1.7 3.6 13.6 6.4 7.4 10.1 9.9 22.4 29.5 0.0 1.0 0.4 3.6 0.6 0.2 0.0 14.9 0.7 KRT13 "CK13, K13, MGC161462, MGC3781" ENSG00000171401 "Keratin 13" P13646 17 41500981-41505705 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 1075.6;lymphoid tissue: 404.8;tongue: 499.8" "Cell type enriched" "Detected in some" 11 "Urothelial cells: 2979.9" "Group enriched" "Detected in many" 5 "cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Group enriched" "Detected in some" 100 "A-431: 216.9;HaCaT: 144.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000133, HPA030877, HPA069771" Enhanced Enhanced "Intermediate filaments" NA NA 1100000000 "Intermediate filaments" "CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141" "unprognostic (1.45e-1)" "unprognostic (6.23e-2)" "unprognostic (1.37e-1)" "unprognostic (2.19e-2)" "unprognostic (9.30e-5)" "unprognostic (7.30e-3)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (5.81e-3)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.45e-6)" "unprognostic (1.80e-1)" "unprognostic (2.76e-1)" "unprognostic (3.04e-2)" "unprognostic (4.33e-1)" 0.3 0.3 0.0 0.3 0.0 0.5 0.3 0.0 0.3 250.9 0.3 0.0 0.0 0.3 13.7 0.3 1075.6 0.3 0.6 0.5 0.0 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.3 0.3 0.3 0.0 0.3 0.0 2.4 0.3 0.1 134.9 0.4 0.4 0.3 0.3 1.7 0.0 0.3 0.3 0.4 0.0 0.6 0.3 499.8 404.8 14.9 222.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 216.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 144.9 0.0 0.0 0.0 0.1 0.0 0.3 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.7 0.0 0.2 0.5 0.4 0.0 0.0 0.0 0.6 0.0 0.5 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.6 1.3 250.4 2.5 0.0 0.6 0.0 1.4 14.8 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.2 66.7 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.2 51.8 0.0 0.0 0.0 0.4 0.0 0.1 2.5 269.4 0.0 0.0 0.0 0.2 0.2 0.4 1.4 0.3 0.0 0.2 2979.9 KRT14 "EBS3, EBS4" ENSG00000186847 "Keratin 14" P02533 17 41582279-41586921 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Ectodermal dysplasia, Epidermolysis bullosa, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skin 1: 439.2;tongue: 363.5" "Group enriched" "Detected in some" 11 "Basal keratinocytes: 31612.6;Suprabasal keratinocytes: 10207.3" "Group enriched" "Detected in many" 6 "cervical cancer: 1263.1;head and neck cancer: 5910.5;melanoma: 1277.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 265.9;HBEC3-KT: 131.1;hTCEpi: 164.0;hTERT-HME1: 53.6;U-2197: 46.3" "Not detected" "Not detected" "CAB000134, HPA000452, HPA000539, HPA023040" Enhanced Enhanced "Intermediate filaments" NA NA 2200000000 "Intermediate filaments" "CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201" "prognostic favorable (2.66e-4)" "unprognostic (1.64e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-2)" "unprognostic (1.66e-1)" "unprognostic (1.02e-2)" "unprognostic (2.03e-2)" "unprognostic (2.74e-1)" "unprognostic (1.35e-1)" "unprognostic (1.00e-2)" "unprognostic (5.74e-3)" "unprognostic (1.49e-8)" "unprognostic (8.91e-2)" "unprognostic (2.00e-1)" "unprognostic (8.80e-3)" "unprognostic (1.22e-2)" 0.2 0.1 0.2 0.2 0.2 0.2 23.1 0.2 0.2 27.0 0.2 0.2 0.2 0.1 0.3 0.2 69.3 0.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 7.6 0.2 2.1 0.1 0.2 30.8 0.3 1.0 439.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 4.6 0.2 363.5 47.6 0.2 37.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 265.9 0.0 131.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 164.0 0.2 53.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 46.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 999.3 31612.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 6.8 0.0 0.0 56.3 2.6 68.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1887.9 0.0 0.0 0.0 0.3 3.5 0.0 0.0 0.0 0.0 75.4 0.0 0.0 10207.3 2.1 0.0 0.2 106.7 KRT16 NEPPK ENSG00000186832 "Keratin 16" P08779 17 41609778-41615899 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "tongue: 503.5" "Group enriched" "Detected in some" 8 "Basal glandular cells: 391.0;Basal keratinocytes: 804.9;Suprabasal keratinocytes: 1178.6;Urothelial cells: 555.3" "Group enriched" "Detected in many" 7 "cervical cancer: 713.1;head and neck cancer: 2720.5;melanoma: 712.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "hTCEpi: 137.6" "Not detected" "Not detected" "CAB000136, HPA000539" Approved Approved "Intermediate filaments" NA NA 2200000000 "Intermediate filaments" "CAB000136: , HPA000539: " "unprognostic (3.95e-3)" "unprognostic (6.90e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (1.41e-2)" "unprognostic (1.00e-2)" "unprognostic (7.14e-3)" "unprognostic (1.03e-3)" "unprognostic (2.05e-1)" "unprognostic (3.07e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (8.23e-2)" "unprognostic (6.53e-8)" "unprognostic (3.81e-1)" "unprognostic (1.83e-1)" "unprognostic (7.40e-2)" "unprognostic (3.61e-2)" 1.6 0.2 0.2 0.2 0.2 0.0 2.1 0.2 0.2 32.4 0.2 0.2 0.2 0.0 1.1 0.2 112.4 0.1 0.6 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.6 0.2 0.7 0.0 0.3 15.5 9.9 0.4 41.4 0.2 0.2 0.2 0.2 0.1 0.6 0.2 3.0 0.2 503.5 26.4 0.6 50.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 4.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 137.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.1 0.0 0.0 15.6 0.1 1.0 0.0 0.0 9.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 391.0 804.9 0.0 0.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.2 2.5 20.6 95.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 60.8 0.0 0.0 0.0 48.1 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 1178.6 0.1 0.0 0.0 555.3 KRT17 PCHC1 ENSG00000128422 "Keratin 17" Q04695 17 41619437-41624842 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 109.0;tongue: 144.0" "Group enriched" "Detected in many" 8 "Basal glandular cells: 10709.5;Urothelial cells: 6883.0" "Cancer enhanced" "Detected in all" "head and neck cancer: 3317.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "hTCEpi: 653.9;SiHa: 272.2" "Not detected" "Not detected" "CAB000029, HPA000452, HPA000453, HPA000539, HPA045062" Enhanced Enhanced "Intermediate filaments" Yes No 750000000 "Intermediate filaments" "CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: AB_2679204" "prognostic favorable (4.44e-4)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (3.65e-3)" "unprognostic (4.46e-2)" "unprognostic (4.34e-1)" "unprognostic (4.36e-3)" "unprognostic (1.32e-2)" "unprognostic (2.27e-1)" "unprognostic (1.29e-1)" "unprognostic (7.86e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (5.74e-4)" "unprognostic (1.82e-1)" "unprognostic (1.77e-1)" "unprognostic (2.20e-1)" "unprognostic (3.89e-1)" 0.7 0.0 0.7 0.7 0.7 0.1 52.3 0.7 0.8 12.6 0.8 0.7 1.2 0.0 1.0 3.1 38.6 0.9 0.9 0.7 0.7 0.0 0.8 0.7 3.7 0.7 0.7 1.0 0.8 0.7 0.0 0.9 4.1 0.8 15.0 0.0 0.7 26.8 33.4 0.7 109.0 0.7 1.2 0.7 0.7 0.0 0.8 0.7 5.1 0.8 144.0 19.7 55.6 25.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 6.5 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 66.1 0.0 67.6 0.0 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 653.9 0.0 50.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.0 24.8 0.0 0.0 272.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.7 0.7 0.8 0.7 0.0 0.7 1.0 0.8 0.7 20.8 7.4 0.0 10709.5 124.0 0.0 0.0 0.0 112.4 563.0 34.9 0.0 2.0 0.0 285.1 0.3 2.9 0.0 0.0 180.6 118.1 9.3 924.1 3.5 0.0 3.5 19.1 1.7 0.0 0.0 1.3 2.0 7.9 10.1 11.8 0.1 0.0 1050.1 0.0 199.8 0.0 0.0 0.0 5.7 0.4 0.2 108.7 4.8 0.5 0.6 6883.0 KRT19 "CK19, K19, K1CS, MGC15366" ENSG00000171345 "Keratin 19" P08727 17 41523617-41528308 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 205.3;intestine: 184.9;placenta: 179.4" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 4255.4;Enterocytes: 4014.8;Extravillous trophoblasts: 5684.1;Pancreatic endocrine cells: 4513.8;Urothelial cells: 5295.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "NK-cell: 2.7" "Lineage enriched" "Detected in single" 4 "NK-cells: 2.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 102.7;HBEC3-KT: 154.6;MCF7: 114.1;RT4: 164.2;SK-BR-3: 290.2;T-47d: 195.5" "Not detected" "Not detected" "CAB000031, HPA002465" Enhanced Supported "Intermediate filaments" NA NA 330000000 "Intermediate filaments" "CAB000031: AB_2234418, HPA002465: AB_1079179" "unprognostic (1.09e-1)" "unprognostic (1.83e-1)" "unprognostic (3.86e-2)" "unprognostic (1.59e-2)" "unprognostic (2.24e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (2.80e-2)" "unprognostic (3.14e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (6.82e-5)" "unprognostic (1.90e-2)" "prognostic unfavorable (2.98e-5)" "unprognostic (3.52e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-2)" "unprognostic (2.35e-2)" 9.8 1.6 0.7 22.8 0.9 0.0 50.1 2.9 0.8 37.4 126.7 1.0 38.0 37.8 9.9 53.0 102.1 19.5 205.3 2.3 0.8 0.2 35.0 2.1 50.6 0.7 0.8 0.8 16.7 7.5 1.2 2.6 179.4 1.3 39.2 40.1 1.8 103.0 46.3 0.7 15.8 184.9 11.7 0.6 0.6 69.1 6.4 0.7 33.3 4.9 21.2 89.2 77.0 35.4 0.0 0.0 0.0 0.0 2.7 0.6 0.2 0.1 18.0 0.0 0.3 0.0 0.1 62.8 21.6 0.0 0.6 0.1 51.6 102.7 0.0 21.2 10.3 0.0 55.0 0.0 154.6 0.1 0.0 0.5 0.0 11.6 35.3 1.6 0.0 4.4 0.0 28.1 0.4 0.0 0.0 1.3 0.0 7.4 0.1 0.0 114.1 0.2 0.1 0.9 68.3 26.1 0.1 0.0 0.3 70.9 164.2 2.1 0.0 0.1 290.2 0.0 15.0 195.5 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.7 0.9 2.9 0.8 0.8 0.2 0.8 0.8 1.3 0.7 625.3 180.1 0.5 3332.5 4.6 0.0 1.4 746.5 641.1 757.5 846.2 0.0 833.1 1.7 4255.4 0.1 5.4 4014.8 0.0 2348.9 5684.1 55.9 1574.4 94.4 0.0 159.5 0.0 348.1 0.6 1.8 0.7 35.1 13.4 180.5 52.3 1103.8 0.6 4513.8 2781.1 83.4 4.2 0.0 0.0 4.6 0.2 0.7 1.0 1779.2 1.0 1201.4 5295.6 KRT35 "Ha-5, KRTHA5" ENSG00000197079 "Keratin 35" Q92764 17 41476689-41481140 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 33.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HDLM-2: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA025750, HPA078713" Enhanced Approved "Intermediate filaments" NA NA 270000000 "Intermediate filaments" "HPA025750: , HPA078713: " 1.8 0.0 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 2.1 0.1 0.1 33.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT4 "CK4, CYK4, K4" ENSG00000170477 "Keratin 4" P19013 12 52806549-52814551 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "esophagus: 637.8;lymphoid tissue: 403.6;tongue: 174.6" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 1: 20.8;Ciliated cells: 56.2;Club cells: 112.6;Urothelial cells: 43.0" "Group enriched" "Detected in many" 5 "cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "HaCaT: 96.5;SK-BR-3: 39.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002154, HPA034881" Enhanced Supported "Intermediate filaments" NA NA 540000000 "Intermediate filaments" "CAB002154: AB_563803, HPA034881: AB_2674370" "unprognostic (4.04e-1)" "unprognostic (3.22e-3)" "unprognostic (5.16e-3)" "unprognostic (8.52e-3)" "unprognostic (1.20e-1)" "unprognostic (2.64e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (2.85e-3)" "unprognostic (2.84e-2)" "unprognostic (2.58e-11)" "unprognostic (1.64e-1)" "unprognostic (6.97e-2)" "unprognostic (1.16e-1)" "prognostic unfavorable (6.26e-4)" 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 25.5 0.1 0.0 0.0 0.1 2.5 0.1 637.8 0.3 0.1 0.2 0.0 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 48.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 174.6 403.6 0.2 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 96.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 3.5 0.0 4.5 0.0 0.0 0.3 0.0 56.2 112.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.0 KRT5 "EBS2, KRT5A" ENSG00000186081 "Keratin 5" P13647 12 52514575-52520687 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 463.1;skin 1: 338.1;tongue: 522.3" "Cell type enhanced" "Detected in some" 30 "Basal glandular cells: 909.3;Basal keratinocytes: 5214.3;Suprabasal keratinocytes: 1765.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 3340.4" "Region enriched" "Detected in single" 7 "pons and medulla: 1.7" "Cell type enriched" "Detected in single" 197 "plasmacytoid DC: 19.6" "Lineage enriched" "Detected in single" 197 "dendritic cells: 19.6" "Cell line enhanced" "Detected in some" "HaCaT: 120.8;HBEC3-KT: 216.3;hTCEpi: 494.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000027, CAB000129, HPA059479" Enhanced Approved "Intermediate filaments" NA NA 6500000000 "Intermediate filaments" "CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034" "prognostic favorable (1.27e-4)" "unprognostic (9.81e-2)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (1.84e-1)" "unprognostic (1.14e-1)" "unprognostic (1.33e-1)" "unprognostic (7.20e-2)" "unprognostic (2.82e-1)" "unprognostic (1.90e-1)" "unprognostic (1.41e-2)" "unprognostic (1.73e-1)" "unprognostic (6.01e-7)" "unprognostic (3.46e-2)" "unprognostic (5.56e-2)" "unprognostic (7.96e-2)" "unprognostic (2.81e-3)" 0.3 0.0 0.1 0.3 0.2 0.2 15.9 0.1 0.2 74.2 0.2 0.3 6.2 0.0 4.9 6.4 463.1 0.7 0.1 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.2 0.1 0.2 0.0 0.2 4.4 1.7 5.8 0.0 0.4 46.9 7.8 0.5 338.1 0.1 0.3 0.1 0.1 0.1 0.7 0.1 31.7 0.1 522.3 128.9 4.0 96.8 0.0 19.6 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 120.8 0.0 216.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 494.5 0.0 43.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.2 1.7 0.1 0.0 0.6 0.0 909.3 5214.3 0.0 0.6 0.0 30.8 153.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 28.8 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 271.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 66.8 0.0 0.0 1765.9 0.0 0.0 0.0 372.4 KRT6A "CK6C, CK6D, K6C, K6D, KRT6C, KRT6D" ENSG00000205420 "Keratin 6A" P02538 12 52487174-52493257 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Allergen, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix, uterine: 209.2;esophagus: 422.1;tongue: 620.2;vagina: 179.1" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 93.8;Suprabasal keratinocytes: 132.4;Urothelial cells: 329.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 3892.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "hTCEpi: 470.1" "HPA045697, HPA061168" Supported Enhanced "Intermediate filaments" NA NA 7200000000 "Intermediate filaments" "HPA045697: AB_2679422, HPA061168: AB_2684440" "unprognostic (8.10e-3)" "unprognostic (2.11e-1)" "unprognostic (2.78e-2)" "unprognostic (1.06e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.45e-4)" "unprognostic (2.43e-1)" "unprognostic (3.73e-2)" "unprognostic (1.31e-3)" "unprognostic (1.29e-1)" "unprognostic (2.89e-9)" "unprognostic (8.80e-2)" "unprognostic (7.20e-2)" "unprognostic (1.72e-1)" "unprognostic (2.13e-2)" 0.2 0.2 0.0 0.4 0.0 0.2 0.8 0.0 0.3 209.2 0.2 0.0 0.0 0.2 6.8 0.2 422.1 0.3 0.3 0.3 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.1 0.2 0.2 0.2 0.0 19.8 0.0 0.3 0.2 0.0 37.6 0.2 0.2 19.0 0.2 0.3 0.0 0.2 0.2 0.2 0.0 2.7 0.2 620.2 86.8 0.5 179.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 53.9 0.0 113.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 470.1 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 32.7 93.8 0.0 0.0 0.0 2.7 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 132.4 0.0 0.0 0.0 329.0 KRT6B KRTL1 ENSG00000185479 "Keratin 6B" P04259 12 52446651-52452126 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 135.3;tongue: 232.4" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 18.3;Ductal cells: 33.5;Suprabasal keratinocytes: 28.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 1424.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 57.1" "CAB000130, HPA045697, HPA061168" Supported Approved "Intermediate filaments" NA NA "Intermediate filaments" "CAB000130: , HPA045697: AB_2679422, HPA061168: AB_2684440" "prognostic favorable (9.44e-4)" "unprognostic (3.27e-2)" "unprognostic (1.93e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (1.75e-2)" "unprognostic (2.07e-3)" "unprognostic (2.27e-1)" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (5.77e-2)" "unprognostic (9.63e-2)" "unprognostic (3.29e-1)" "prognostic unfavorable (9.52e-4)" 0.2 0.1 0.1 0.5 0.1 0.1 3.9 0.1 0.1 33.3 0.1 0.1 0.1 0.1 0.7 0.1 135.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 17.8 0.1 0.1 34.9 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.1 232.4 15.4 0.1 26.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.1 0.4 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.8 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 1.5 0.0 0.0 0.0 1.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 28.5 0.0 0.0 0.0 4.8 KRT6C KRT6E ENSG00000170465 "Keratin 6C" P48668 12 52468516-52473785 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 109.4;esophagus: 125.8;tongue: 244.2" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 3.1;Suprabasal keratinocytes: 2.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 564.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 46.0" "HPA045697, HPA061168" Supported Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA045697: AB_2679422, HPA061168: AB_2684440" "unprognostic (3.18e-2)" "unprognostic (6.26e-3)" "unprognostic (6.63e-2)" "unprognostic (1.54e-3)" "unprognostic (6.97e-2)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.83e-1)" "unprognostic (1.87e-2)" "unprognostic (3.25e-2)" "unprognostic (2.24e-1)" "unprognostic (2.84e-1)" "unprognostic (4.50e-2)" 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 109.4 0.2 0.0 0.0 0.2 1.1 0.2 125.8 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 16.3 0.2 0.2 2.7 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.1 0.2 244.2 6.7 0.2 40.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 KRT8 "CARD2, CK8, CYK8, K2C8, K8, KO" ENSG00000170421 "Keratin 8" P05787 12 52897187-52949954 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 102.9" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 5778.2;Enterocytes: 4471.9;Exocrine glandular cells: 4777.1;Extravillous trophoblasts: 4560.4;Pancreatic endocrine cells: 3911.0;Syncytiotrophoblasts: 4406.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "pons and medulla: 13.7" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.9" "Group enriched" "Detected in many" 4 "dendritic cells: 4.9;granulocytes: 3.2;NK-cells: 1.6" "Cell line enhanced" "Detected in many" "A549: 228.5;BEWO: 153.1;CACO-2: 284.3;CAPAN-2: 179.6;MCF7: 383.7;SK-BR-3: 195.0;T-47d: 164.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000131, CAB001696, HPA049866" Enhanced Supported "Intermediate filaments" NA NA 920000000 "Intermediate filaments" "CAB000131: AB_2281144, CAB001696: , HPA049866: AB_2680923" "unprognostic (5.72e-2)" "unprognostic (2.29e-1)" "unprognostic (2.49e-2)" "unprognostic (1.52e-1)" "unprognostic (2.76e-2)" "unprognostic (4.86e-3)" "unprognostic (3.10e-2)" "unprognostic (2.52e-2)" "unprognostic (1.92e-1)" "unprognostic (4.58e-1)" "prognostic unfavorable (1.51e-4)" "unprognostic (8.99e-2)" "unprognostic (2.08e-2)" "unprognostic (2.83e-2)" "unprognostic (3.18e-1)" "unprognostic (3.68e-1)" "unprognostic (1.19e-2)" 13.4 4.8 2.0 11.0 1.5 0.0 13.9 2.7 1.3 15.1 90.2 2.1 29.8 87.2 11.1 18.3 19.3 10.4 20.3 17.6 1.1 0.2 28.8 55.8 20.1 18.4 1.4 1.2 10.6 75.9 4.0 31.8 28.9 13.7 25.2 45.0 12.1 36.9 46.0 3.7 5.0 102.9 5.2 3.3 14.3 61.8 5.1 1.2 2.9 27.6 9.2 11.6 27.1 10.5 0.7 4.9 3.2 0.7 1.6 0.6 0.5 101.4 228.5 0.0 0.3 0.0 0.1 153.1 0.4 1.8 0.2 0.2 284.3 179.6 0.0 43.4 0.5 0.2 35.5 0.6 28.1 0.2 0.1 4.9 0.1 47.6 81.3 8.3 0.0 0.0 0.3 0.4 0.5 1.9 16.2 0.6 0.0 17.4 0.0 0.0 383.7 0.2 0.3 15.9 100.9 5.0 0.1 0.0 0.5 45.2 50.4 4.9 0.1 39.7 195.0 0.3 50.7 164.0 0.3 0.7 0.2 17.2 0.3 0.3 0.0 0.2 0.2 0.1 0.0 0.5 3.2 0.5 0.6 0.6 0.7 0.4 0.3 0.4 0.3 2.1 0.7 0.4 0.5 1.4 1.6 0.3 4.9 0.5 0.5 2.0 1.5 2.7 1.3 1.1 0.2 1.4 1.2 13.7 1.2 372.2 157.7 26.9 1665.1 5.4 2.4 26.3 1065.0 434.9 350.3 465.9 0.0 1661.4 252.0 5778.2 13.8 28.9 4471.9 0.0 4777.1 4560.4 56.5 694.5 77.0 253.1 223.9 1.6 905.1 28.3 8.4 52.9 7.5 27.5 124.9 94.6 2325.6 3.9 3911.0 3583.7 1.8 388.7 3.8 0.0 11.3 1.1 4.1 1.5 4406.3 7.5 1775.0 1380.2 KRT80 KB20 ENSG00000167767 "Keratin 80" Q6KB66 12 52168996-52192000 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.9;skin 1: 64.0;tongue: 41.8" "Cell type enhanced" "Detected in some" 13 "Ductal cells: 70.7;Pancreatic endocrine cells: 32.8;Suprabasal keratinocytes: 32.6;Syncytiotrophoblasts: 48.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 44.6;MCF7: 63.7;SK-BR-3: 29.5;U-2 OS: 41.3" "Region enhanced" "Detected in single" "cerebral cortex: 5.7" "Low region specificity" "Detected in all" "HPA077836, HPA077918" Enhanced "Intermediate filaments" No No 290000000 "Intermediate filaments" "HPA077836: AB_2686857, HPA077918: AB_2686871" "prognostic unfavorable (1.05e-4)" "unprognostic (5.45e-3)" "unprognostic (5.35e-2)" "unprognostic (9.19e-3)" "unprognostic (2.85e-4)" "unprognostic (6.68e-2)" "unprognostic (2.06e-3)" "unprognostic (1.26e-3)" "unprognostic (5.60e-2)" "unprognostic (4.06e-2)" "unprognostic (7.06e-3)" "unprognostic (1.02e-1)" "unprognostic (8.79e-3)" "unprognostic (8.85e-2)" "unprognostic (2.03e-1)" "unprognostic (1.51e-1)" "unprognostic (2.98e-2)" 0.2 1.9 0.1 0.0 0.2 0.0 3.9 0.0 0.1 5.7 0.5 0.0 1.5 0.0 0.5 4.2 20.4 1.4 1.8 0.2 0.0 0.1 2.7 0.2 1.5 0.0 0.0 0.0 0.6 9.0 7.3 0.2 17.5 0.0 1.8 0.0 0.1 22.1 1.6 0.9 64.0 0.5 0.0 0.1 0.1 0.2 0.5 0.0 0.8 0.4 41.8 43.9 3.2 10.7 0.1 0.9 0.3 0.9 0.0 0.1 0.0 44.6 15.0 0.0 0.0 0.0 0.0 12.5 0.6 0.4 3.5 1.0 1.0 19.6 0.0 22.0 0.5 23.2 22.3 0.0 0.3 1.2 0.0 0.0 0.0 23.4 0.5 2.4 0.0 0.0 0.2 2.7 0.8 5.4 16.4 5.3 0.0 0.0 0.0 1.2 63.7 0.0 0.0 0.0 13.0 2.3 0.0 18.4 0.6 20.1 8.0 5.7 0.3 11.3 29.5 0.2 1.3 5.5 0.2 3.0 0.0 41.3 0.0 16.0 0.0 0.0 0.1 4.2 1.6 0.2 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.1 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.5 5.6 0.0 0.3 10.2 6.7 1.2 10.4 0.0 19.7 0.0 70.7 0.6 0.0 0.0 0.0 17.4 0.6 0.7 4.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 32.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 32.6 48.7 0.0 0.0 7.8 MAFIP "FLJ00219, FLJ35473, FLJ39633, MIP, pp5644, TEKT4P4" ENSG00000274847 "MAFF interacting protein (pseudogene)" Unmapped 53594-115055 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 10.5" "Cell type enhanced" "Detected in some" 8 "Cytotrophoblasts: 1.2;Pancreatic endocrine cells: 1.3;Proximal tubular cells: 1.4;Syncytiotrophoblasts: 1.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 15.7" HPA053929 Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA053929: AB_2682314" 2.9 5.1 0.5 0.0 0.2 0.9 0.4 0.3 0.7 1.1 0.1 2.0 1.0 1.2 1.4 1.6 1.2 1.0 2.3 2.4 1.6 0.0 0.5 1.7 0.0 2.5 0.3 1.1 0.0 1.5 1.4 2.0 0.0 0.2 1.3 0.3 1.9 5.4 10.5 2.5 5.6 4.5 4.8 3.5 0.2 3.6 0.0 1.4 0.0 0.0 4.0 3.6 1.8 1.1 1.4 6.5 8.2 0.1 7.4 4.8 5.5 0.9 2.8 3.9 0.7 0.3 3.5 5.8 3.8 6.6 0.3 0.1 9.3 0.6 5.5 3.3 0.0 4.4 3.5 0.0 15.7 8.4 2.4 7.1 5.1 1.1 0.2 4.7 3.0 0.0 4.7 3.7 3.9 1.0 3.1 5.8 0.0 5.3 6.4 2.7 11.7 0.4 9.0 2.3 6.5 3.0 2.9 8.0 6.1 0.0 9.9 0.0 2.3 2.4 4.8 2.5 3.7 5.6 3.1 5.3 3.7 3.5 6.0 5.4 4.6 4.6 0.3 4.5 2.9 10.5 4.8 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.7 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 NEFM "NEF3, NF-M, NFM" ENSG00000104722 "Neurofilament medium" P07197 8 24913012-24919098 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 144.7" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 26.9;Early spermatids: 68.8;Late spermatids: 86.3;Rod photoreceptor cells: 46.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "MAIT T-cell: 1.0;memory CD4 T-cell: 1.0;naive CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enriched" "Detected in some" 23 "HEK 293: 292.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010900, CAB012976, HPA022845, HPA023138" Enhanced Enhanced "Intermediate filaments" Yes NA "Intermediate filaments" "CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398" "unprognostic (1.41e-2)" "unprognostic (1.83e-1)" "unprognostic (2.59e-2)" "unprognostic (9.38e-2)" "unprognostic (5.17e-2)" "unprognostic (6.32e-3)" "unprognostic (6.10e-3)" "unprognostic (2.57e-1)" "unprognostic (8.55e-3)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-2)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (4.76e-2)" "unprognostic (2.61e-2)" 1.5 18.9 20.3 2.0 24.2 1.3 1.3 10.9 87.6 9.7 2.0 5.6 0.0 1.3 3.8 1.3 4.7 1.3 1.4 1.3 36.1 25.0 2.2 1.2 1.3 1.3 52.2 22.4 2.0 2.5 1.2 3.3 1.4 144.7 2.5 1.9 3.4 1.3 26.9 1.9 1.3 1.5 3.3 26.7 1.3 1.5 12.4 4.9 0.0 1.3 0.0 1.6 1.3 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 292.9 0.0 0.0 0.0 6.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.3 24.2 10.9 71.9 36.1 25.0 52.2 22.4 144.7 4.9 0.0 0.0 0.0 0.1 1.1 26.9 2.0 0.0 0.0 1.2 0.0 5.9 0.0 0.0 0.0 68.8 0.6 0.0 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.1 19.1 3.4 0.0 0.0 86.3 0.9 0.0 1.7 0.0 0.0 20.8 0.0 0.0 4.2 0.4 46.9 0.0 1.3 2.2 1.3 0.3 0.0 0.0 0.0 0.3 NES FLJ21841 ENSG00000132688 Nestin P48681 1 156668763-156677397 "Plasma proteins, Predicted intracellular proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 77.9" "Cell type enhanced" "Detected in many" 19 "Cardiomyocytes: 191.0;Endothelial cells: 67.1;Sertoli cells: 103.5;Smooth muscle cells: 44.2" "Group enriched" "Detected in all" 6 "glioma: 147.0;melanoma: 101.4;testis cancer: 34.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 92.5;HUVEC TERT2: 46.8;LHCN-M2: 74.7;RH-30: 76.5;SuSa: 52.8;WM-115: 36.1" "Low region specificity" "Detected in all" "CAB005889, HPA006286, HPA007007, HPA026111, CAB058692" Enhanced Enhanced "Intermediate filaments" No No "Intermediate filaments" "CAB005889: AB_2251301, CAB058692: AB_2665584, HPA006286: AB_2667550, HPA007007: AB_1854381, HPA026111: AB_1854382" "unprognostic (7.73e-2)" "unprognostic (2.05e-1)" "unprognostic (2.80e-2)" "unprognostic (1.36e-1)" "unprognostic (6.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-1)" "unprognostic (4.40e-2)" "unprognostic (7.56e-2)" "unprognostic (9.84e-2)" "unprognostic (4.49e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (8.02e-7)" "unprognostic (2.87e-1)" "unprognostic (2.48e-1)" "unprognostic (6.67e-2)" "unprognostic (8.11e-3)" 22.1 4.2 6.2 7.1 7.6 0.4 13.8 6.0 13.3 16.9 5.9 13.0 7.5 3.1 23.4 12.3 10.0 12.5 8.9 77.9 6.5 5.1 15.7 4.5 16.0 4.2 8.2 5.1 13.2 2.2 7.5 5.6 8.9 12.8 14.6 4.0 12.2 3.8 20.0 25.3 3.2 4.9 16.1 12.0 26.8 4.2 5.3 6.2 0.4 8.0 16.8 3.5 12.7 17.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 92.5 19.7 0.2 5.1 0.0 22.3 17.6 0.3 0.5 14.6 0.2 0.0 5.3 2.1 0.0 0.4 9.3 0.0 0.2 0.0 0.1 0.1 1.3 6.6 0.8 0.0 5.5 4.3 0.0 0.8 0.0 0.7 46.8 0.0 0.6 0.0 74.7 0.6 0.0 0.0 15.0 0.8 12.8 0.1 76.5 0.0 0.0 0.0 0.2 14.9 0.5 0.6 17.2 52.8 0.2 0.1 33.8 0.1 5.2 0.6 1.2 0.0 3.3 0.0 2.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 7.6 6.0 6.3 6.5 5.1 8.2 5.1 12.8 6.2 0.0 7.9 0.0 0.4 2.2 0.3 191.0 0.0 0.0 1.2 17.4 0.0 0.2 0.0 1.4 0.4 67.1 0.0 0.0 0.0 1.9 14.4 0.4 0.0 0.0 1.5 0.0 0.0 23.4 0.6 0.0 7.5 1.1 1.7 1.8 0.0 13.2 0.4 0.0 3.9 0.0 1.1 103.5 44.2 0.5 3.1 2.0 0.1 0.0 0.0 0.3 PAFAH1B3 ENSG00000079462 "Platelet activating factor acetylhydrolase 1b catalytic subunit 3" Q15102 19 42297033-42303546 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatogonia: 212.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035639 Uncertain Approved "Intermediate filaments" NA NA 370000 "Intermediate filaments" "HPA035639: AB_10670163" "unprognostic (3.19e-1)" "unprognostic (5.38e-3)" "unprognostic (1.13e-1)" "unprognostic (5.99e-2)" "unprognostic (1.83e-1)" "unprognostic (2.09e-2)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.73e-1)" "unprognostic (2.67e-1)" "unprognostic (6.36e-2)" "unprognostic (2.37e-1)" "unprognostic (7.67e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (2.68e-1)" "unprognostic (3.21e-2)" "unprognostic (4.56e-2)" "unprognostic (6.80e-3)" 4.5 12.8 23.8 10.4 23.2 20.7 12.2 36.4 24.9 17.2 14.6 7.8 8.0 10.9 10.1 11.9 15.5 13.5 9.6 4.6 15.4 25.7 11.7 5.6 5.8 13.6 13.9 13.1 15.4 11.9 8.3 11.8 5.8 12.4 10.3 10.7 11.2 9.8 6.1 10.8 10.6 11.2 6.6 11.7 9.5 11.3 16.3 11.3 37.4 7.8 13.8 15.4 14.6 10.9 19.6 24.6 8.7 13.6 7.8 27.4 10.5 29.3 53.8 33.6 35.9 0.7 1.8 10.4 7.4 10.2 24.3 25.2 17.9 24.7 18.1 9.7 8.9 16.9 10.0 15.2 19.4 10.1 27.4 20.8 21.9 14.4 24.0 5.2 13.9 24.4 5.3 9.0 14.9 7.0 13.5 10.8 39.7 15.4 21.6 17.7 42.9 31.0 10.9 18.6 34.8 0.0 23.0 12.9 16.2 19.7 31.0 38.7 30.3 11.8 23.4 12.3 11.1 29.2 15.9 5.8 20.2 27.4 1.8 19.9 10.3 21.3 15.4 11.3 22.5 17.7 8.7 13.6 7.2 12.1 10.7 16.1 19.6 17.3 13.9 24.6 18.4 23.0 16.0 1.8 7.8 5.4 13.6 27.4 10.5 23.8 23.2 36.4 24.9 15.4 25.7 13.9 13.1 12.4 11.3 14.9 9.1 22.3 37.0 25.0 24.5 1.2 28.1 30.8 15.9 31.4 13.7 30.1 68.0 88.9 12.7 17.1 21.2 23.3 48.0 33.8 21.6 29.7 27.6 7.2 52.3 11.1 56.6 9.2 23.0 16.4 12.7 23.2 43.9 10.8 47.4 24.0 78.6 24.6 8.5 40.4 17.2 0.0 6.2 4.3 212.2 15.6 11.3 17.5 63.6 43.4 PGM2 FLJ10983 ENSG00000169299 "Phosphoglucomutase 2" Q96G03 4 37826633-37862937 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 345.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040676 Uncertain Approved "Intermediate filaments" NA NA 1900000 "Intermediate filaments" "HPA040676: AB_2677076" "unprognostic (3.11e-2)" "unprognostic (1.01e-2)" "prognostic favorable (2.14e-5)" "unprognostic (2.29e-1)" "unprognostic (3.94e-1)" "unprognostic (5.44e-2)" "unprognostic (1.70e-2)" "unprognostic (2.09e-3)" "unprognostic (5.32e-2)" "unprognostic (7.02e-2)" "unprognostic (5.37e-2)" "unprognostic (2.22e-2)" "unprognostic (6.72e-3)" "unprognostic (3.21e-2)" "unprognostic (1.88e-1)" "unprognostic (9.97e-2)" "unprognostic (1.02e-1)" 11.2 10.8 7.7 11.6 5.9 7.5 13.5 9.8 5.7 14.7 10.3 4.2 6.5 6.1 15.0 7.6 41.3 7.0 11.0 8.3 7.1 4.0 11.1 13.3 7.5 13.2 4.4 5.7 10.0 9.0 9.5 6.4 27.9 10.4 11.1 8.4 6.8 11.0 5.0 2.4 17.7 8.6 12.2 6.9 13.4 9.0 9.0 3.9 17.3 8.8 31.7 22.9 13.6 18.9 4.5 15.3 30.8 13.1 13.2 7.0 7.2 11.7 4.1 6.3 6.7 4.7 5.3 8.3 14.2 8.4 11.7 12.0 7.2 8.6 15.5 7.1 7.7 15.6 6.1 15.3 13.3 29.8 9.9 8.8 17.0 6.9 5.1 10.3 17.8 11.9 7.7 16.1 9.5 8.6 7.3 18.6 13.7 22.1 2.8 10.2 6.2 20.3 21.1 7.3 8.5 6.4 15.5 10.0 6.4 7.2 22.7 13.3 4.5 7.1 10.5 4.9 9.1 9.1 19.2 16.2 8.8 10.8 11.8 28.8 6.3 16.4 17.6 4.6 23.4 14.6 8.0 13.1 30.8 4.9 10.5 5.8 4.5 4.1 5.6 15.3 2.8 4.0 5.0 16.3 13.2 8.0 3.4 7.0 7.2 7.7 5.9 9.8 5.7 7.1 4.0 4.4 5.7 10.4 3.9 0.0 8.0 10.3 13.2 13.1 5.8 4.5 7.6 5.3 4.5 3.5 0.0 26.6 5.0 13.0 0.8 25.5 7.9 0.0 10.4 30.7 6.7 18.4 12.7 7.3 33.4 6.4 6.9 44.8 19.6 0.9 7.8 24.9 5.0 52.3 9.0 345.3 11.4 3.5 9.2 7.4 13.5 12.9 23.7 0.7 0.5 28.1 66.7 12.9 12.3 17.9 PJA2 "KIAA0438, Neurodap1, RNF131" ENSG00000198961 "Praja ring finger ubiquitin ligase 2" O43164 5 109334709-109409994 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040347, HPA057636" Supported Enhanced "Intermediate filaments" No No "Intermediate filaments" "HPA040347: AB_10795631, HPA057636: AB_2683485" "unprognostic (5.78e-2)" "unprognostic (1.25e-1)" "unprognostic (5.48e-3)" "unprognostic (1.17e-1)" "unprognostic (2.99e-1)" "unprognostic (7.83e-2)" "unprognostic (2.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.84e-2)" "prognostic unfavorable (8.02e-4)" "unprognostic (4.46e-2)" "unprognostic (6.03e-2)" "unprognostic (5.64e-3)" "unprognostic (1.47e-3)" "unprognostic (5.94e-2)" "unprognostic (7.59e-2)" "unprognostic (1.00e-2)" 21.6 27.0 40.1 15.9 49.9 29.0 22.1 41.6 63.0 29.0 23.8 19.7 16.8 12.5 29.2 25.0 20.7 20.3 18.6 24.4 44.3 46.2 24.1 29.2 19.4 14.3 36.8 44.0 35.4 14.8 42.8 30.3 21.8 53.2 31.7 20.6 12.5 17.3 37.7 17.1 13.6 15.9 39.2 37.6 19.5 15.8 17.0 27.4 16.7 35.9 9.7 16.3 35.5 21.4 10.3 11.7 29.9 15.5 10.7 12.2 10.6 11.8 8.2 33.3 25.6 33.1 36.3 18.1 19.6 29.6 15.5 25.5 7.6 16.2 15.3 27.2 37.6 25.0 6.9 19.4 24.1 28.5 13.0 7.3 17.7 16.9 10.3 23.5 13.2 26.3 25.0 20.2 20.7 29.9 27.9 24.7 13.8 12.1 28.9 25.0 7.2 15.8 12.2 6.6 7.3 5.5 10.3 29.3 25.5 24.1 10.7 6.4 16.4 20.2 7.4 23.6 23.3 16.7 19.6 28.4 22.1 10.8 20.3 9.1 19.5 16.6 18.2 23.4 18.4 14.5 17.3 11.6 17.3 9.5 12.2 9.4 10.3 9.4 8.7 11.7 7.4 12.1 8.9 29.9 10.7 15.5 4.9 12.2 10.6 40.1 49.9 41.6 63.0 44.3 46.2 36.8 44.0 53.2 27.4 62.5 47.1 47.1 45.8 56.3 93.5 116.8 50.9 41.5 45.5 54.1 58.9 19.9 41.4 32.7 16.4 64.5 53.5 0.0 28.7 23.4 57.5 66.5 46.2 90.1 46.6 73.1 64.9 65.1 78.4 15.1 78.9 53.7 57.3 31.5 47.8 99.2 29.4 20.1 87.0 45.1 78.2 77.6 80.4 73.2 30.2 50.8 22.0 50.7 29.6 32.0 PTPN18 BDP1 ENSG00000072135 "Protein tyrosine phosphatase, non-receptor type 18" Q99952 2 130356007-130375409 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB012174, HPA053367" Uncertain Approved "Intermediate filaments" NA NA 550000 "Intermediate filaments" "CAB012174: AB_2173224, HPA053367: AB_2732579" "unprognostic (3.11e-3)" "unprognostic (2.89e-3)" "unprognostic (1.67e-3)" "unprognostic (1.73e-3)" "unprognostic (5.81e-3)" "unprognostic (3.08e-3)" "unprognostic (2.49e-2)" "unprognostic (1.28e-2)" "unprognostic (4.65e-1)" "unprognostic (2.10e-2)" "unprognostic (7.33e-2)" "unprognostic (5.65e-2)" "unprognostic (4.52e-2)" "unprognostic (1.00e-2)" "unprognostic (3.60e-1)" "unprognostic (1.05e-1)" "unprognostic (5.85e-3)" 12.8 7.1 11.0 16.7 13.5 18.9 22.3 26.8 13.7 15.3 22.8 6.6 25.7 16.6 9.3 11.0 11.3 13.3 21.3 7.5 9.8 8.5 13.9 19.2 16.9 29.2 8.4 9.5 7.8 28.9 6.4 11.0 9.4 6.9 17.8 19.3 7.9 18.5 24.0 11.0 6.9 28.8 10.5 9.1 37.7 16.0 3.3 9.1 1.6 13.0 7.1 35.5 11.0 10.7 7.6 7.4 6.2 17.1 2.8 6.6 10.2 5.8 3.9 1.6 7.9 9.9 6.8 16.4 3.0 2.7 3.9 4.4 7.8 9.0 21.9 3.0 7.3 1.8 6.7 6.9 6.8 3.8 9.9 3.8 7.9 4.7 9.2 5.1 7.7 21.5 8.0 5.6 4.3 5.9 0.8 7.4 4.9 7.4 16.7 7.4 11.4 1.4 13.4 1.6 12.6 4.3 13.3 4.6 29.6 7.7 3.6 10.1 2.6 5.3 19.0 8.7 1.6 6.6 11.4 6.9 5.6 6.3 3.0 2.8 2.6 0.7 21.1 8.5 7.0 6.0 6.2 7.8 6.1 6.6 10.8 4.1 7.6 4.4 6.3 6.7 4.5 2.7 5.4 4.9 2.8 17.1 7.4 5.6 10.2 11.0 13.5 26.8 13.7 9.8 8.5 8.4 9.5 6.9 9.1 26.8 22.9 49.5 26.1 5.8 13.5 8.1 20.4 18.7 12.5 34.9 3.9 12.1 46.4 16.6 0.7 21.5 49.1 0.0 39.9 25.3 13.3 43.8 35.7 18.1 76.6 9.5 46.7 17.2 79.3 0.9 17.5 52.8 32.1 16.2 50.4 12.4 23.4 56.1 10.6 25.1 10.0 19.4 19.8 3.0 4.1 5.1 9.6 39.8 38.3 27.6 PTPRE PTPE ENSG00000132334 "Protein tyrosine phosphatase, receptor type E" P23469 10 127907061-128085855 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 91.0" "Cell type enhanced" "Detected in many" 10 "Kupffer cells: 141.1;Macrophages: 249.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 91.0;plasmacytoid DC: 65.7" "Group enriched" "Detected in all" 11 "dendritic cells: 65.7;granulocytes: 91.0;monocytes: 25.5" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 18.8;HUVEC TERT2: 19.8;NB-4: 14.9;TIME: 37.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015870, HPA021872" Supported Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA015870: AB_1855759, HPA021872: AB_1855760" "unprognostic (5.23e-2)" "unprognostic (1.37e-1)" "unprognostic (1.99e-1)" "unprognostic (7.11e-2)" "unprognostic (3.19e-1)" "unprognostic (9.67e-2)" "unprognostic (6.50e-2)" "unprognostic (4.49e-2)" "unprognostic (2.11e-1)" "unprognostic (2.56e-2)" "unprognostic (8.71e-3)" "unprognostic (2.00e-1)" "prognostic unfavorable (4.08e-5)" "unprognostic (1.52e-1)" "unprognostic (6.71e-3)" "unprognostic (2.49e-2)" "unprognostic (5.59e-2)" 16.8 18.5 12.5 24.0 12.5 39.5 11.0 7.4 15.3 4.8 9.2 14.5 1.6 9.6 5.1 8.1 8.8 6.2 10.7 12.3 15.0 12.2 4.4 4.8 22.5 20.0 12.5 6.5 4.3 3.1 3.4 6.5 8.0 9.8 4.5 9.8 4.8 7.0 3.1 1.9 4.9 12.7 7.7 14.3 26.4 7.7 4.3 10.9 11.4 6.6 6.1 12.2 10.0 5.0 1.2 65.7 91.0 25.5 4.0 5.4 4.9 1.9 0.4 0.2 0.0 1.2 0.2 3.6 0.0 0.0 0.8 1.7 0.8 12.0 1.5 1.3 1.0 2.6 1.1 1.0 5.7 0.3 1.8 0.9 0.1 0.7 0.0 2.0 7.4 5.6 0.4 3.3 2.9 5.9 18.8 19.8 4.9 0.0 0.9 1.2 1.8 2.2 14.9 0.1 2.1 0.7 8.8 1.2 2.9 3.3 8.5 0.0 1.2 3.4 0.6 0.1 0.9 0.3 9.4 37.4 0.8 0.8 3.7 4.1 0.4 0.6 2.1 5.5 5.8 0.0 17.4 25.5 19.3 5.4 9.0 3.2 0.9 2.4 3.6 13.3 1.2 1.7 2.9 91.0 4.0 6.8 65.7 3.5 4.9 12.5 12.5 7.4 12.7 15.0 12.2 12.5 6.5 9.8 10.9 77.4 67.6 24.7 47.2 52.9 2.6 15.1 5.1 9.4 33.0 3.5 0.0 33.6 0.0 4.3 1.6 49.4 12.3 0.0 4.0 40.5 9.9 8.3 30.1 1.3 53.6 0.0 6.4 46.1 141.1 1.7 0.6 249.1 23.6 4.6 14.4 0.0 28.7 11.5 0.4 1.9 0.8 0.0 8.1 0.5 1.4 56.6 14.2 52.4 10.2 34.4 RAB3IP "FLJ22548, RABIN3, RABIN8" ENSG00000127328 "RAB3A interacting protein" Q96QF0 12 69738681-69823204 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Bipolar cells: 217.9;Early spermatids: 250.3;Late spermatids: 317.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 52.8" "Low region specificity" "Detected in all" HPA039794 Uncertain Approved "Intermediate filaments" No No "Intermediate filaments" "HPA039794: AB_10960557" "unprognostic (4.38e-3)" "unprognostic (1.48e-1)" "unprognostic (6.66e-2)" "unprognostic (8.57e-2)" "unprognostic (3.30e-3)" "unprognostic (1.95e-1)" "unprognostic (1.75e-2)" "unprognostic (7.10e-2)" "unprognostic (2.12e-1)" "unprognostic (1.31e-1)" "unprognostic (1.16e-2)" "unprognostic (1.24e-1)" "prognostic favorable (5.68e-13)" "unprognostic (6.17e-2)" "unprognostic (1.20e-1)" "unprognostic (1.15e-1)" "unprognostic (3.37e-1)" 3.4 10.2 15.9 6.2 17.2 13.7 12.3 49.7 17.9 5.2 12.9 14.0 8.2 11.9 3.5 28.5 6.0 9.3 9.6 11.2 15.8 11.3 29.9 10.2 9.1 7.7 15.0 11.2 3.2 15.0 15.9 24.4 7.3 25.9 13.2 14.1 22.4 9.9 12.0 7.7 8.6 13.4 3.1 14.9 5.6 11.1 42.6 12.1 8.7 9.6 2.6 9.1 5.5 7.6 10.2 5.9 7.4 5.7 7.6 12.4 5.0 14.9 8.1 4.7 8.1 2.4 1.1 14.7 1.5 3.4 5.9 8.2 23.7 6.8 11.9 4.9 0.8 7.8 11.5 4.6 8.0 10.4 17.2 8.7 8.4 3.1 11.2 2.3 9.4 5.4 2.5 8.3 5.4 18.8 6.1 8.6 14.7 4.0 10.7 3.4 16.2 9.3 4.4 12.7 15.7 9.0 11.4 7.4 12.4 19.6 18.7 19.0 3.5 5.5 9.6 2.2 21.3 17.1 3.9 2.4 2.5 6.7 1.0 6.6 4.9 19.5 52.8 5.9 6.2 4.0 1.9 5.7 7.3 4.8 2.0 9.5 10.2 8.5 7.7 5.9 9.1 10.8 10.3 7.4 7.6 2.3 5.5 12.4 5.0 15.9 17.2 49.7 15.5 15.8 11.3 15.0 11.2 25.9 12.1 56.6 41.9 9.8 44.6 20.9 217.9 43.6 81.5 42.8 54.6 48.8 104.1 18.8 31.5 58.7 250.3 9.0 33.9 23.3 27.6 7.0 6.9 68.5 2.3 15.6 3.1 27.0 39.2 4.3 1.8 317.8 4.0 6.1 5.0 18.0 32.4 97.7 42.5 31.6 3.5 65.3 93.1 6.5 4.9 48.1 25.3 26.1 7.1 7.9 41.7 65.8 RGS4 SCZD9 ENSG00000117152 "Regulator of G protein signaling 4" P49798 1 163068775-163076802 "Disease related genes, Predicted intracellular proteins" "Signal transduction inhibitor" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 88.0" "Cell type enhanced" "Detected in some" 25 "Early spermatids: 10.1;Intestinal endocrine cells: 49.4;Muller glia cells: 14.1;Smooth muscle cells: 10.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 91.6;LHCN-M2: 36.1;SH-SY5Y: 71.9;TIME: 146.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030802 Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA030802: AB_10602295" "unprognostic (1.03e-1)" "unprognostic (1.84e-1)" "unprognostic (3.02e-2)" "unprognostic (6.84e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (8.26e-2)" "unprognostic (1.27e-1)" "unprognostic (5.34e-3)" "unprognostic (1.82e-1)" "unprognostic (6.45e-2)" "unprognostic (2.12e-2)" "unprognostic (8.47e-2)" "prognostic unfavorable (3.97e-4)" "prognostic unfavorable (1.92e-4)" "unprognostic (1.00e-1)" "unprognostic (8.33e-2)" "unprognostic (2.30e-2)" 2.9 20.9 9.1 2.1 45.3 0.5 1.4 1.1 88.0 4.0 1.7 1.0 0.0 2.9 4.8 1.4 6.3 4.9 11.2 4.7 13.9 10.1 1.5 2.6 2.1 2.3 12.1 36.2 1.1 2.7 1.2 6.2 1.3 16.0 3.3 1.8 1.0 0.9 3.9 0.7 0.6 1.6 3.0 1.9 1.5 3.7 2.1 2.1 0.0 1.5 0.2 0.7 2.8 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 3.5 18.5 0.0 12.5 13.6 1.8 4.8 0.0 0.0 0.0 5.5 8.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.0 0.0 19.7 2.4 91.6 19.1 0.0 0.0 0.0 36.1 0.0 0.0 0.0 1.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.4 71.9 0.0 0.0 0.0 0.7 0.0 0.0 146.6 14.9 0.7 2.9 20.7 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 9.1 45.3 1.1 78.8 13.9 10.1 12.1 36.2 16.0 2.1 0.0 0.0 0.0 0.8 0.2 0.2 0.5 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 10.1 0.5 0.0 0.0 0.2 0.0 1.7 0.5 0.0 0.0 0.4 0.0 49.4 0.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 14.1 4.1 0.0 0.0 0.0 1.6 0.0 10.3 0.0 0.2 0.3 0.1 0.0 0.0 0.1 RWDD4 "FAM28A, MGC10198, RWDD4A" ENSG00000182552 "RWD domain containing 4" Q6NW29 4 183639635-183659225 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036501, HPA036502" Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA036501: AB_2675159, HPA036502: AB_10670800" "unprognostic (1.30e-1)" "unprognostic (4.15e-1)" "unprognostic (7.50e-2)" "unprognostic (2.30e-1)" "unprognostic (7.80e-2)" "unprognostic (1.72e-1)" "unprognostic (1.13e-1)" "unprognostic (1.97e-2)" "unprognostic (6.27e-2)" "unprognostic (2.21e-2)" "unprognostic (4.68e-2)" "unprognostic (2.98e-1)" "prognostic favorable (1.01e-6)" "unprognostic (6.77e-2)" "unprognostic (1.14e-1)" "unprognostic (3.51e-2)" "unprognostic (4.65e-2)" 11.0 37.4 8.3 9.3 8.2 8.5 14.8 10.0 7.5 10.0 11.6 8.1 10.6 7.6 9.7 12.1 16.0 9.7 11.6 15.7 7.8 9.1 17.6 13.3 10.3 9.9 8.4 6.1 28.6 17.9 7.1 28.4 10.3 8.1 12.2 8.5 8.9 25.6 13.6 30.7 8.2 11.2 10.4 8.4 11.4 9.5 12.3 7.7 10.6 17.1 17.7 10.5 13.2 13.7 7.4 8.5 11.8 9.7 11.4 9.9 6.4 13.3 7.8 12.0 14.7 19.3 20.5 9.1 16.9 13.5 21.4 13.6 5.0 17.6 20.2 4.0 13.8 10.3 6.3 16.6 15.8 22.6 13.4 7.4 14.6 9.2 12.8 13.7 22.4 11.1 13.3 16.5 11.7 13.1 16.6 16.0 15.9 13.9 26.4 22.3 5.6 22.9 18.9 8.0 5.1 10.2 16.0 9.3 12.8 20.9 6.5 11.5 16.2 15.9 18.7 14.6 9.6 9.4 13.6 11.6 9.0 4.4 9.6 13.0 8.9 6.6 6.9 16.9 16.6 12.7 6.0 6.1 11.8 8.6 8.2 8.4 7.4 7.8 8.1 8.0 5.2 7.4 7.7 5.3 11.4 9.7 8.5 9.9 6.4 8.3 8.2 10.0 7.5 7.8 9.1 8.4 6.1 8.1 7.7 20.8 15.0 21.6 28.9 29.9 17.0 9.4 28.1 29.4 20.5 17.4 5.9 22.5 63.0 27.5 5.6 26.2 14.0 0.0 67.9 34.3 27.8 53.7 35.7 29.7 32.4 9.5 20.8 19.0 31.4 7.3 68.4 22.4 54.0 30.7 25.4 27.0 45.6 10.5 66.4 98.2 21.6 19.4 33.3 39.5 54.4 31.0 22.7 26.1 24.3 39.9 SESTD1 "DKFZp434O0515, Solo" ENSG00000187231 "SEC14 and spectrin domain containing 1" Q86VW0 2 179101692-179264790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Horizontal cells: 284.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 4.3" "Group enriched" "Detected in many" 4 "B-cells: 4.3;dendritic cells: 1.1;monocytes: 3.7" "Cell line enhanced" "Detected in many" "ASC diff: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058236, HPA077408" Approved Enhanced "Intermediate filaments" NA NA "Intermediate filaments" "HPA058236: AB_2732619, HPA077408: AB_2732344" "unprognostic (2.76e-1)" "unprognostic (3.55e-2)" "unprognostic (2.77e-1)" "unprognostic (2.12e-1)" "unprognostic (1.78e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (9.47e-2)" "unprognostic (1.64e-1)" "unprognostic (2.59e-1)" "unprognostic (7.91e-3)" "unprognostic (9.21e-2)" "prognostic favorable (2.78e-11)" "prognostic unfavorable (2.67e-4)" "unprognostic (3.25e-2)" "unprognostic (1.25e-1)" "unprognostic (2.57e-2)" 23.6 5.0 11.2 6.5 11.3 8.1 32.1 10.3 17.0 12.7 10.0 15.8 9.1 4.3 11.1 7.9 8.8 6.4 12.0 9.6 13.5 9.9 12.7 6.5 16.9 6.2 14.4 9.4 9.0 6.2 8.9 7.2 12.5 12.7 9.4 7.6 7.6 16.6 9.2 5.7 7.0 8.7 22.5 21.0 6.5 9.1 15.9 11.5 3.7 6.1 6.2 9.1 19.9 23.7 4.3 1.1 0.2 3.7 0.6 0.1 0.6 0.0 1.2 15.5 2.8 28.2 12.3 8.2 5.4 2.2 2.3 3.9 2.7 3.6 2.6 7.2 5.1 2.8 2.5 6.5 3.0 4.1 1.9 1.8 3.2 7.0 7.2 2.2 1.7 1.4 9.1 1.3 3.5 8.8 5.4 9.1 2.7 0.5 1.4 3.8 1.8 4.1 0.2 4.0 2.7 1.6 6.0 10.2 1.7 6.2 13.7 3.4 5.8 4.7 2.1 1.5 12.0 0.3 2.0 15.9 7.6 3.9 3.8 2.7 0.8 0.0 6.4 3.8 0.7 2.2 0.0 2.1 0.0 0.0 1.8 0.0 2.7 0.1 0.0 1.1 4.3 0.1 0.0 0.2 0.6 3.7 0.0 0.1 0.6 11.2 11.3 10.3 16.1 13.5 9.9 14.4 9.4 12.7 11.5 101.3 25.1 16.2 20.3 8.8 27.5 13.3 12.7 24.1 21.6 12.2 17.7 7.6 14.9 23.4 6.1 21.5 17.0 0.0 23.7 53.0 41.0 56.1 0.0 8.1 11.3 284.4 24.0 19.0 24.6 6.0 11.2 24.9 13.5 1.0 5.8 32.4 30.0 14.0 28.7 30.6 10.6 19.4 24.5 31.7 61.3 8.8 15.1 4.3 6.4 58.7 SFRP2 "FRP-2, SARP1, SDF-5" ENSG00000145423 "Secreted frizzled related protein 2" Q96HF1 4 153780592-153789120 "Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 102.5" "Group enriched" "Detected in some" 15 "Basal keratinocytes: 102.6;Fibroblasts: 163.9;Melanocytes: 113.1;Smooth muscle cells: 47.4;Suprabasal keratinocytes: 92.6" "Cancer enhanced" "Detected in all" "pancreatic cancer: 370.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "AF22: 53.5;ASC diff: 20.3;HSkMC: 33.5;NTERA-2: 74.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA002652 Approved "Intermediate filaments" "Secreted in other tissues" NA NA "Intermediate filaments" "HPA002652: AB_2732394" "unprognostic (2.63e-1)" "unprognostic (2.47e-1)" "unprognostic (7.21e-3)" "unprognostic (1.80e-2)" "unprognostic (2.73e-1)" "unprognostic (8.80e-3)" "unprognostic (5.71e-3)" "unprognostic (2.62e-2)" "unprognostic (2.79e-1)" "unprognostic (7.47e-3)" "unprognostic (1.44e-2)" "unprognostic (5.29e-2)" "prognostic unfavorable (8.56e-6)" "unprognostic (9.29e-3)" "unprognostic (4.72e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.39e-4)" 42.9 4.0 3.4 17.6 1.7 0.2 70.0 1.3 8.0 10.9 20.6 11.3 18.2 4.4 6.4 64.4 51.5 18.5 74.9 42.2 8.5 1.2 1.9 0.2 21.3 2.6 2.8 5.6 7.9 22.5 1.6 23.2 0.3 4.6 33.4 10.8 8.4 23.9 19.5 2.5 26.1 13.7 72.3 5.4 0.3 11.4 13.2 5.0 0.3 29.1 29.4 6.8 102.5 37.4 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 53.5 0.0 20.3 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.4 1.7 1.3 5.7 8.5 1.2 2.8 5.6 4.6 5.0 3.0 1.1 0.0 0.6 102.6 0.0 0.3 0.0 5.3 3.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 163.9 0.3 1.1 0.0 3.3 0.0 0.0 0.0 0.0 0.2 3.7 2.2 113.1 1.0 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.0 47.4 0.0 0.2 92.6 0.1 0.0 0.0 1.0 SLC10A3 "DXS253E, P3" ENSG00000126903 "Solute carrier family 10 member 3" P09131 X 154487306-154490690 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 9 "basophil: 51.2" "Lineage enriched" "Detected in all" 13 "granulocytes: 51.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021656 Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA021656: AB_1856955" "unprognostic (1.60e-1)" "prognostic favorable (4.53e-4)" "prognostic unfavorable (4.15e-5)" "unprognostic (8.00e-3)" "prognostic unfavorable (9.97e-4)" "unprognostic (5.47e-2)" "unprognostic (2.28e-3)" "unprognostic (9.76e-2)" "unprognostic (1.63e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.22e-4)" "unprognostic (3.42e-1)" "unprognostic (2.52e-3)" "unprognostic (6.23e-2)" "unprognostic (2.99e-1)" "unprognostic (7.29e-2)" "unprognostic (2.99e-2)" 14.5 14.6 3.6 11.6 5.1 22.5 13.4 5.0 8.1 21.5 15.3 8.1 16.3 10.6 25.0 36.1 22.8 15.4 21.1 19.5 6.0 4.6 17.7 6.7 16.3 14.0 5.8 6.2 32.3 25.7 6.1 12.7 40.1 7.6 23.7 6.4 12.4 11.7 13.3 13.7 26.2 13.6 20.1 5.3 13.1 12.6 11.6 4.7 12.6 15.7 23.3 18.6 23.3 18.3 1.6 2.7 51.2 1.7 2.2 3.8 1.8 24.9 10.7 2.9 14.6 10.1 11.0 19.0 18.6 11.4 12.6 12.7 9.5 12.1 19.0 35.4 17.8 16.8 21.5 9.4 9.5 3.4 12.3 4.4 5.9 14.1 7.5 18.6 7.0 9.6 13.7 10.9 11.7 6.3 11.3 8.6 3.3 6.6 18.7 8.2 33.1 3.8 6.3 2.2 12.2 20.8 6.1 7.7 14.4 9.5 9.3 2.6 4.7 11.7 21.3 4.9 3.5 6.8 5.6 11.3 15.0 9.4 34.8 23.5 13.4 12.9 19.6 16.0 14.7 7.7 51.2 1.3 5.6 3.8 1.7 2.9 1.6 2.6 2.8 1.1 1.6 1.9 1.8 1.7 2.2 1.5 2.7 1.8 1.8 3.6 5.1 5.0 8.1 6.0 4.6 5.8 6.2 7.6 4.7 3.0 6.5 11.7 23.8 20.0 2.0 3.6 7.6 4.0 3.4 17.4 5.9 42.9 6.6 15.3 2.4 14.3 14.4 0.0 17.0 52.6 23.3 12.1 12.7 1.6 17.2 3.2 9.8 18.4 7.8 1.0 25.0 10.5 3.3 16.2 14.0 2.3 15.9 15.3 12.4 7.7 1.6 6.5 22.6 1.2 2.7 24.3 86.2 17.5 10.6 24.7 SYCE1L MRP2 ENSG00000205078 "Synaptonemal complex central element protein 1 like" A8MT33 16 77199397-77213215 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 22.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 13.0;U-698: 10.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062464, HPA066691" Enhanced "Intermediate filaments" No No "Intermediate filaments" "HPA062464: , HPA066691: AB_2685702" "unprognostic (5.54e-3)" "unprognostic (2.15e-1)" "unprognostic (1.65e-1)" "prognostic favorable (6.65e-4)" "unprognostic (1.32e-1)" "unprognostic (2.32e-1)" "unprognostic (3.48e-2)" "unprognostic (2.00e-3)" "unprognostic (6.28e-3)" "unprognostic (1.02e-1)" "unprognostic (7.48e-2)" "unprognostic (5.13e-2)" "prognostic unfavorable (2.11e-5)" "unprognostic (9.27e-2)" "unprognostic (4.27e-1)" "unprognostic (2.68e-2)" "unprognostic (1.73e-2)" 3.5 3.4 2.8 4.1 2.7 2.9 3.7 5.2 2.4 8.7 5.0 0.4 11.5 2.1 7.8 7.6 4.4 2.8 1.8 7.0 2.8 3.0 4.3 1.4 1.9 4.5 2.1 1.4 8.5 2.7 2.3 2.3 1.6 1.5 6.6 1.6 5.4 11.1 8.7 1.7 4.3 4.6 2.0 2.5 4.2 2.3 22.4 0.4 6.4 8.0 2.0 2.4 2.3 4.4 3.5 12.2 12.0 2.2 2.7 10.5 3.4 2.8 1.1 2.8 1.3 0.3 0.0 0.5 0.8 0.3 0.5 0.9 0.6 5.7 1.9 3.8 0.6 0.2 4.1 0.2 0.0 0.3 1.7 13.0 0.4 1.0 0.0 1.9 0.9 1.2 0.1 0.4 0.1 0.3 0.5 2.0 2.6 0.7 0.2 0.3 4.2 0.7 1.3 1.9 0.4 4.5 6.7 0.7 0.6 2.5 0.8 2.9 3.4 0.4 0.3 0.0 0.3 0.1 1.2 6.5 0.4 6.5 0.9 0.2 5.5 2.1 10.1 2.8 0.7 0.2 4.0 1.3 12.0 6.1 2.2 7.3 3.5 7.9 8.4 1.6 2.6 8.7 8.0 1.3 2.7 1.6 12.2 10.5 3.4 2.8 2.7 5.2 2.2 2.8 3.0 2.1 1.4 1.5 0.4 3.0 3.0 6.0 9.6 15.3 3.7 2.0 30.6 1.4 5.7 26.2 9.8 5.2 13.3 23.2 19.5 7.5 6.9 0.0 24.3 3.8 9.0 15.6 1.1 10.6 2.1 1.6 21.6 16.5 13.5 35.7 12.7 3.1 18.6 2.8 30.3 14.0 19.1 22.4 6.3 17.9 35.5 6.5 4.2 34.7 8.1 14.9 2.4 13.4 29.9 5.7 SYNM "DMN, KIAA0353, SYN" ENSG00000182253 Synemin O15061 15 99098217-99135593 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 111.2;smooth muscle: 147.5;urinary bladder: 85.2" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 422.4;Muller glia cells: 107.8;Smooth muscle cells: 184.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 8 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "A549: 14.9;HeLa: 22.3;WM-115: 50.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017192, HPA040066, HPA044200, HPA077856" Enhanced Supported "Intermediate filaments" NA NA "Intermediate filaments" "CAB017192: , HPA040066: AB_2676830, HPA044200: AB_2678854, HPA077856: AB_2686861" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.10e-2)" "unprognostic (1.87e-1)" "unprognostic (1.15e-1)" "unprognostic (3.52e-2)" "unprognostic (1.10e-1)" "unprognostic (2.54e-1)" "unprognostic (1.00e-1)" "unprognostic (1.34e-2)" "unprognostic (6.75e-2)" "unprognostic (3.54e-3)" "unprognostic (2.80e-2)" "unprognostic (7.27e-2)" "unprognostic (5.92e-3)" "unprognostic (3.26e-3)" 6.9 4.2 4.5 5.0 5.4 0.0 11.9 2.5 5.5 2.9 38.4 9.0 27.6 5.4 4.9 7.2 42.1 3.1 9.6 24.8 6.0 5.7 0.8 0.8 2.0 0.7 11.8 4.2 2.9 0.9 1.8 2.0 2.7 8.5 30.1 11.1 10.9 3.2 62.6 111.2 1.5 11.9 147.5 18.2 0.6 16.7 1.5 3.7 0.0 1.4 14.5 1.7 85.2 21.6 0.2 0.1 0.1 0.0 0.2 1.8 0.4 2.6 14.9 3.3 8.9 6.7 0.3 0.2 1.4 2.1 0.9 0.5 2.1 2.0 0.0 2.2 2.1 7.3 1.7 2.2 0.0 0.7 0.2 3.7 0.0 22.3 2.1 3.8 0.0 0.4 0.4 0.1 1.5 0.3 2.5 1.7 0.0 0.0 3.0 2.2 1.4 0.2 0.3 2.9 0.2 4.7 0.0 3.1 2.1 0.8 1.4 1.5 1.7 8.8 1.3 5.3 5.5 0.0 1.4 1.9 1.7 0.2 1.1 3.5 0.0 0.4 0.0 0.1 0.0 50.6 0.1 0.0 0.0 1.7 0.0 1.4 0.2 1.8 1.1 0.1 0.0 1.6 0.6 0.0 0.2 0.0 0.0 0.0 0.4 4.5 5.4 2.5 4.4 6.0 5.7 11.8 4.2 8.5 3.7 0.0 1.7 0.0 0.9 2.1 11.5 422.4 0.0 4.0 1.2 0.0 15.7 1.0 0.0 0.4 7.1 10.8 1.1 0.0 1.2 0.3 4.0 2.0 0.0 0.8 0.2 39.7 2.9 2.5 0.0 3.4 1.1 1.4 5.0 0.0 0.1 107.8 0.2 0.3 3.9 0.3 7.8 32.3 184.3 3.7 11.9 3.1 0.3 2.9 0.2 0.7 TBC1D16 "FLJ20748, MGC25062" ENSG00000167291 "TBC1 domain family member 16" Q8TBP0 17 79932343-80035848 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 290.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "intermediate monocyte: 4.6;naive B-cell: 1.5;non-classical monocyte: 4.7" "Group enriched" "Detected in many" 6 "B-cells: 1.5;monocytes: 4.7" "Cell line enhanced" "Detected in many" "ASC diff: 52.5;SK-MEL-30: 55.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024482, HPA065839" Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA024482: AB_1857790, HPA065839: AB_2685566" "unprognostic (4.53e-3)" "unprognostic (1.36e-2)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" "unprognostic (4.92e-2)" "unprognostic (7.21e-2)" "unprognostic (1.05e-3)" "unprognostic (1.72e-1)" "unprognostic (5.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (9.76e-2)" "unprognostic (1.52e-3)" "unprognostic (3.02e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-3)" "unprognostic (3.99e-3)" 32.2 8.1 10.1 7.8 18.2 1.0 32.6 25.5 11.2 10.7 8.6 6.0 28.4 7.5 11.9 20.9 9.8 12.8 9.3 10.0 8.1 7.8 18.1 13.2 8.5 13.7 8.7 5.6 11.8 18.7 9.3 6.6 7.1 8.2 17.3 5.8 15.4 25.5 24.2 4.5 15.8 7.9 10.8 8.1 8.7 7.6 5.2 9.5 2.7 9.7 7.0 3.9 9.2 14.6 1.5 0.3 0.1 4.7 0.1 0.5 0.3 8.2 7.9 12.3 14.4 52.5 27.7 2.3 4.8 4.8 3.0 3.5 14.8 2.9 0.0 3.4 8.1 5.8 2.6 12.9 4.5 2.3 0.4 6.1 0.0 3.6 6.8 8.9 0.1 1.1 31.1 8.0 6.6 4.8 4.9 13.0 5.6 1.9 5.6 5.7 5.1 2.1 0.7 14.7 10.8 4.3 6.9 7.8 4.7 3.6 10.2 12.6 16.3 4.3 12.1 55.7 8.0 7.9 3.7 8.7 10.7 7.7 8.4 4.2 17.2 3.0 0.9 4.6 3.1 13.5 0.0 0.3 0.0 0.1 4.6 0.5 0.0 0.1 0.2 0.3 1.5 0.2 0.3 0.1 0.1 4.7 0.0 0.0 0.3 10.1 18.2 25.5 11.2 8.1 7.8 8.7 5.6 8.2 9.5 0.0 9.3 0.8 3.6 4.8 6.6 7.2 17.8 2.7 2.3 7.0 9.8 5.2 8.3 13.8 1.0 9.0 3.2 0.0 19.3 1.1 12.8 9.6 7.0 16.2 3.0 290.8 30.5 15.4 43.0 1.6 5.5 3.8 72.6 1.0 6.4 21.5 16.9 2.8 7.4 10.0 7.4 6.5 10.5 0.2 3.4 4.0 1.6 3.8 5.0 5.7 TEKT4 MGC27019 ENSG00000163060 "Tektin 4" Q8WW24 2 94871433-94876829 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 7.6;testis: 21.1" "Group enriched" "Detected in many" 14 "Ciliated cells: 66.9;Early spermatids: 109.5;Late spermatids: 99.2" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 2.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 1.0;fHDF/TERT166: 1.8;HEK 293: 1.0;HEL: 1.3;HMC-1: 1.0;MCF7: 1.5" "HPA048600, HPA053929, HPA069872" Enhanced Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA048600: AB_2680460, HPA053929: AB_2682314, HPA069872: " "unprognostic (1.49e-2)" "unprognostic (4.00e-1)" "prognostic favorable (1.29e-4)" "unprognostic (9.95e-2)" "unprognostic (1.25e-1)" "unprognostic (2.35e-3)" "unprognostic (2.82e-3)" "unprognostic (2.15e-1)" "unprognostic (5.25e-2)" "unprognostic (5.00e-2)" "unprognostic (9.01e-2)" "unprognostic (5.25e-3)" "unprognostic (5.45e-3)" "unprognostic (2.33e-1)" "unprognostic (3.27e-2)" "unprognostic (7.56e-3)" 0.1 0.1 0.7 0.2 1.5 0.1 0.1 0.2 0.2 0.6 0.1 1.4 0.7 0.1 0.5 5.5 0.1 7.6 0.1 0.1 0.9 0.9 0.1 0.1 3.7 0.1 0.1 0.2 1.7 0.2 0.1 0.0 0.1 2.9 0.1 0.1 0.0 0.7 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 21.1 0.3 0.0 1.0 0.0 0.1 0.1 0.0 1.1 1.8 0.7 0.6 0.1 0.8 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.3 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.7 0.6 0.4 0.3 1.1 0.6 0.7 0.8 0.6 0.8 0.5 0.0 0.1 0.6 1.8 0.6 0.3 0.7 1.5 0.2 0.2 0.9 0.9 0.1 0.2 2.9 0.3 0.0 1.0 0.0 0.2 1.3 0.0 0.3 2.5 66.9 5.7 1.8 0.0 0.5 1.7 1.2 109.5 0.9 0.0 0.0 0.3 0.2 1.4 0.4 1.1 0.9 0.2 0.0 0.0 1.8 0.3 99.2 2.6 0.9 0.0 4.6 0.0 0.0 1.2 0.0 1.1 6.3 0.0 6.5 0.9 1.1 0.6 1.1 0.5 0.0 0.1 0.3 TMEM81 "HC3107, KVLA2788, MGC75217, UNQ2788" ENSG00000174529 "Transmembrane protein 81" Q6P7N7 1 205083129-205084460 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.2" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 3.5;Early spermatids: 7.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052515 Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA052515: AB_2681858" "unprognostic (9.19e-3)" "unprognostic (3.53e-1)" "unprognostic (1.91e-3)" "unprognostic (6.48e-2)" "unprognostic (2.44e-1)" "unprognostic (2.08e-1)" "prognostic unfavorable (3.25e-6)" "unprognostic (3.66e-2)" "unprognostic (2.68e-2)" "unprognostic (6.18e-2)" "unprognostic (5.86e-2)" "unprognostic (2.48e-2)" "prognostic unfavorable (6.65e-9)" "unprognostic (8.91e-2)" "unprognostic (6.24e-2)" "unprognostic (2.42e-1)" "prognostic favorable (2.67e-4)" 1.5 2.7 2.8 1.6 3.8 2.0 2.1 11.2 5.3 2.1 1.3 1.2 1.5 3.5 1.4 1.2 1.1 2.2 3.3 2.7 4.2 3.3 1.5 2.3 2.8 2.3 1.0 3.4 2.2 2.0 1.8 1.7 1.4 2.1 4.6 4.1 1.2 1.7 2.4 3.0 1.0 6.1 1.4 2.7 0.9 1.6 1.5 1.5 4.3 1.4 0.2 4.6 0.9 2.4 3.7 6.2 8.1 9.1 3.6 3.1 4.5 2.7 2.3 1.4 6.5 1.7 4.5 3.2 2.5 3.4 2.1 9.9 3.8 4.0 3.9 3.9 3.7 5.2 3.2 6.3 1.9 2.1 3.6 6.8 3.6 1.8 6.1 4.5 5.4 8.3 1.9 2.9 4.7 4.3 8.1 4.7 3.0 5.4 3.0 7.1 4.6 5.3 2.3 3.9 6.1 2.8 3.4 7.1 10.0 2.5 8.0 2.1 4.3 2.3 5.5 4.8 4.3 5.3 3.6 6.2 2.9 7.3 4.3 1.2 0.2 4.6 1.4 0.2 1.5 2.3 1.1 1.5 1.4 2.5 4.0 2.5 0.2 1.4 1.5 2.7 0.9 0.0 0.0 0.5 0.5 2.1 0.6 1.2 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.5 7.9 1.0 0.3 0.0 0.5 0.3 0.8 0.6 0.0 1.0 0.5 1.6 0.0 0.6 0.0 1.3 0.0 0.0 1.7 0.0 0.2 1.1 0.7 0.0 0.4 1.4 1.0 0.0 0.6 0.2 1.1 2.3 0.1 0.0 0.8 0.4 TRIM32 "BBS11, HT2A, LGMD2H, TATIP" ENSG00000119401 "Tripartite motif containing 32" Q13049 9 116687302-116701300 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Limb-girdle muscular dystrophy, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050060 Approved Approved "Intermediate filaments" No No "Intermediate filaments" "HPA050060: AB_2681000" "unprognostic (2.47e-2)" "unprognostic (7.06e-3)" "unprognostic (5.50e-2)" "unprognostic (3.63e-1)" "unprognostic (5.08e-2)" "prognostic unfavorable (4.53e-4)" "prognostic unfavorable (4.72e-4)" "unprognostic (2.41e-3)" "unprognostic (2.92e-1)" "unprognostic (5.01e-2)" "unprognostic (1.79e-2)" "unprognostic (5.63e-2)" "unprognostic (6.03e-2)" "unprognostic (7.06e-2)" "unprognostic (2.73e-1)" "unprognostic (6.64e-3)" "unprognostic (9.77e-2)" 9.5 9.1 6.6 5.8 11.5 0.8 8.0 23.2 17.1 12.8 7.9 7.2 6.2 6.7 17.0 8.0 8.8 15.9 8.2 8.9 5.7 7.3 6.2 5.0 6.3 8.4 5.7 9.8 12.6 12.5 12.2 7.7 7.0 9.1 10.3 7.4 10.4 10.9 9.2 23.9 6.6 8.9 12.9 5.3 6.9 6.8 6.5 2.2 9.4 8.4 6.2 8.3 11.1 8.8 6.1 3.5 0.2 2.6 5.6 16.0 4.7 6.5 15.0 8.9 9.8 18.1 13.0 6.7 12.2 13.4 13.9 11.7 10.0 7.2 6.8 5.4 18.7 10.4 14.0 10.8 13.7 12.7 5.9 5.2 3.6 9.7 6.1 9.4 2.4 12.0 11.2 12.4 13.1 7.8 15.4 9.0 7.6 5.0 5.8 16.3 8.4 6.4 0.0 8.1 15.8 9.1 7.6 24.0 4.4 5.7 15.3 8.9 4.5 9.6 6.7 6.9 9.4 18.5 2.4 11.1 13.0 10.4 9.5 9.1 9.5 2.5 10.6 10.8 1.6 12.7 0.0 1.3 0.0 9.3 2.6 7.2 6.1 8.2 7.4 1.8 4.4 8.3 8.4 0.2 5.6 2.1 3.5 16.0 4.7 6.6 11.5 23.2 17.1 5.7 7.3 5.7 9.8 9.1 2.2 6.0 1.1 3.0 5.1 3.8 11.5 6.1 7.6 6.7 5.7 8.7 0.0 6.0 1.7 7.8 2.8 2.4 2.4 0.0 7.0 3.6 6.5 2.8 2.3 3.9 5.8 1.6 4.1 2.5 2.7 1.3 4.9 1.4 1.7 1.0 5.2 4.1 4.9 3.5 11.3 2.2 4.5 0.0 3.6 9.8 11.1 3.1 6.2 4.6 4.9 3.4 TTBK2 "KIAA0847, SCA11" ENSG00000128881 "Tau tubulin kinase 2" Q6IQ55 15 42738734-42920809 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.8" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 69.2;Late spermatids: 113.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018113, HPA049866" Approved Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA018113: AB_1858421, HPA049866: AB_2680923" "unprognostic (2.15e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (7.73e-2)" "unprognostic (4.26e-1)" "unprognostic (6.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.43e-2)" "unprognostic (2.78e-2)" "unprognostic (8.62e-2)" "unprognostic (3.46e-2)" "unprognostic (7.29e-2)" "unprognostic (3.63e-2)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" 6.7 7.3 8.7 5.1 14.0 8.0 6.0 17.8 22.0 7.0 7.2 10.9 3.8 3.3 8.5 6.2 4.2 7.8 6.2 10.7 9.4 11.5 6.1 4.3 6.1 5.5 11.1 14.8 11.5 3.3 9.0 13.9 8.8 24.7 8.2 5.6 7.6 4.8 6.5 11.6 6.3 4.6 8.4 10.9 7.1 4.9 41.8 10.8 3.6 6.7 1.9 5.4 6.8 8.7 2.5 1.4 1.3 3.0 2.1 3.1 0.7 6.2 3.4 9.3 4.9 6.4 6.6 1.9 5.1 7.3 4.4 6.6 4.6 1.5 4.0 6.5 4.9 8.9 4.2 8.1 6.0 6.8 13.0 5.7 5.0 7.7 1.9 5.0 7.1 8.6 5.2 6.2 4.0 21.0 9.6 5.5 5.4 7.5 6.5 4.2 0.8 4.7 5.0 2.6 1.5 3.8 7.9 8.8 2.0 5.6 3.8 6.9 7.8 12.5 0.9 2.6 6.7 3.2 8.8 6.7 5.7 5.7 7.1 7.1 7.6 10.1 6.0 4.2 5.5 3.6 0.4 3.0 1.2 1.7 1.4 3.1 1.5 1.6 1.3 0.8 2.5 2.1 1.5 1.3 2.1 1.5 1.4 0.5 0.7 8.7 14.0 17.8 22.0 9.4 11.5 11.1 14.8 24.7 10.8 6.0 10.2 7.4 11.8 9.5 31.0 14.2 15.3 33.5 9.1 8.7 35.3 3.5 0.0 4.9 69.2 12.8 3.6 23.3 3.7 2.6 13.1 11.0 18.5 6.8 6.4 42.9 13.7 12.9 13.9 113.0 15.5 15.4 11.8 9.0 4.9 15.0 6.5 2.9 19.1 4.5 38.8 12.9 18.9 39.4 7.1 8.2 2.6 8.7 5.2 5.5 VIM ENSG00000026025 Vimentin P08670 10 17228259-17237593 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Leydig cells: 4641.8;monocytes: 4064.1;Muller glia cells: 7582.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 560.5;fHDF/TERT166: 291.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000080, HPA001762, CAB058687" Enhanced Supported "Intermediate filaments" NA NA 19000000 "Intermediate filaments" "CAB000080: AB_2304493, CAB058687: AB_2665570, HPA001762: AB_1080568" "unprognostic (1.02e-1)" "unprognostic (2.58e-1)" "unprognostic (2.87e-2)" "prognostic favorable (9.75e-6)" "unprognostic (3.81e-2)" "unprognostic (2.52e-1)" "unprognostic (3.21e-1)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (2.05e-1)" "unprognostic (9.29e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (8.69e-8)" "unprognostic (1.87e-3)" "unprognostic (7.32e-2)" "unprognostic (1.82e-1)" "unprognostic (9.47e-3)" 254.1 29.2 29.3 51.3 36.2 93.6 285.0 7.5 21.1 137.6 58.0 29.9 46.0 15.8 92.6 100.0 78.4 80.7 71.3 94.8 30.5 14.5 38.7 15.5 100.5 171.0 37.6 26.1 302.9 27.1 32.1 46.2 95.0 38.3 90.5 30.6 161.6 42.6 43.4 52.3 76.2 43.1 101.6 50.7 93.0 38.3 69.8 20.1 56.8 142.0 74.6 73.1 99.2 139.1 24.3 112.1 68.9 90.4 12.2 60.8 61.0 0.5 32.4 58.7 93.6 194.6 560.5 0.0 152.4 101.5 115.0 102.8 0.2 2.0 0.0 8.1 291.2 53.8 0.2 8.3 4.2 112.3 101.1 11.3 16.0 16.6 0.0 59.9 8.4 6.6 204.9 0.1 169.6 96.4 270.2 186.6 10.8 24.8 46.5 203.6 0.1 20.6 25.8 18.6 0.0 40.9 16.0 81.5 2.6 115.3 0.0 0.2 28.2 0.0 0.2 153.2 35.3 0.2 9.7 158.2 114.7 49.7 96.0 180.6 52.2 26.4 3.7 173.2 0.8 109.0 68.9 90.4 26.5 30.0 59.5 38.6 24.3 49.6 39.1 112.1 14.9 30.8 30.0 53.5 12.2 55.9 44.9 60.8 61.0 29.3 36.2 7.5 20.7 30.5 14.5 37.6 26.1 38.3 20.1 145.9 453.1 371.8 18.9 644.8 57.5 74.2 58.6 109.7 257.0 102.9 47.1 20.9 5.0 163.9 46.6 2159.6 2.6 0.0 486.0 33.2 3109.4 58.3 2616.8 8.9 3605.1 31.8 297.4 1271.2 2430.7 64.7 4641.8 2952.8 2923.7 4064.1 1.1 7582.7 699.8 1.1 2196.4 90.2 214.0 1397.0 3660.6 56.4 19.3 413.4 44.1 597.7 2.6 17.7 WDR37 KIAA0982 ENSG00000047056 "WD repeat domain 37" Q9Y2I8 10 1049538-1132297 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 168.7;Late spermatids: 73.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037376, HPA037565" Enhanced Approved "Intermediate filaments" No No "Intermediate filaments" "HPA037376: AB_10672789, HPA037565: AB_10696937" "unprognostic (1.50e-2)" "unprognostic (2.07e-1)" "unprognostic (9.08e-3)" "unprognostic (8.51e-3)" "unprognostic (1.81e-1)" "prognostic favorable (1.75e-5)" "unprognostic (2.59e-3)" "unprognostic (3.56e-2)" "unprognostic (1.80e-1)" "unprognostic (1.62e-2)" "prognostic favorable (1.46e-6)" "unprognostic (3.16e-1)" "unprognostic (4.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.34e-5)" "unprognostic (5.98e-2)" 10.6 17.4 26.3 11.4 24.2 24.5 10.4 19.4 35.4 7.4 9.2 11.8 10.1 9.8 9.4 12.1 9.9 9.3 8.3 22.1 25.7 14.1 9.7 10.7 10.9 14.6 12.0 29.5 12.4 11.4 12.1 16.3 8.8 16.0 9.5 9.0 10.6 8.9 7.6 21.9 14.9 11.9 8.9 11.7 23.3 11.6 23.3 16.8 7.1 12.8 8.1 12.5 7.7 8.5 7.3 6.7 7.5 8.6 14.0 14.1 6.3 9.4 6.8 8.9 7.3 8.6 12.5 6.8 12.2 6.5 7.3 7.3 8.7 8.2 5.1 7.7 15.4 1.5 9.3 4.7 13.8 6.4 6.9 8.5 11.4 6.7 5.8 6.2 6.9 13.1 15.9 10.6 10.4 3.8 8.9 16.2 9.7 7.7 5.6 11.6 8.3 7.1 5.2 5.1 7.2 4.4 11.5 5.3 8.0 10.2 10.2 4.2 8.8 5.7 10.4 9.3 7.1 9.9 13.5 21.6 6.0 2.3 19.4 9.5 12.6 10.5 6.7 13.7 7.6 4.3 7.5 6.3 4.7 14.1 8.5 12.0 7.3 8.1 10.4 6.7 6.7 9.1 10.3 6.0 14.0 8.6 6.3 6.8 6.3 26.3 24.2 19.4 35.4 25.7 14.1 12.0 29.5 16.0 16.8 3.0 7.2 6.2 10.5 11.8 14.2 22.2 0.0 2.7 7.9 10.4 11.8 5.3 0.0 4.0 168.7 9.6 5.6 0.0 5.2 3.5 5.5 10.7 11.5 6.7 8.0 7.9 10.3 31.9 20.6 73.7 11.5 12.1 15.1 3.6 8.4 6.1 6.4 7.6 17.0 3.3 14.2 6.5 9.5 11.6 15.8 10.8 9.5 10.2 5.7 11.6 ZFP36 "G0S24, NUP475, RNF162A, TIS11, TTP" ENSG00000128016 "ZFP36 ring finger protein" 19 39406813-39409412 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Smooth muscle cells: 1665.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 72.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 32.0;ASC TERT1: 41.6;hTCEpi: 50.6;Karpas-707: 43.7;U-266/70: 32.2;U-266/84: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006009 Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA006009: AB_1859030" "unprognostic (2.30e-2)" "unprognostic (2.27e-1)" "unprognostic (8.26e-2)" "unprognostic (6.76e-2)" "unprognostic (4.74e-3)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (4.59e-2)" "unprognostic (5.20e-1)" "unprognostic (3.61e-3)" "unprognostic (9.44e-2)" "unprognostic (3.11e-1)" "unprognostic (4.20e-3)" "unprognostic (5.22e-3)" "unprognostic (1.35e-1)" "unprognostic (7.05e-2)" "unprognostic (6.92e-3)" 109.7 49.3 7.7 112.8 40.3 90.1 63.0 7.5 26.2 60.2 52.9 25.4 12.4 22.8 47.3 23.9 121.7 98.2 78.0 32.5 28.8 7.9 23.2 43.8 124.6 24.9 10.9 2.3 53.9 21.5 29.3 31.4 20.8 47.7 55.8 26.4 45.3 34.3 46.6 82.9 61.6 58.0 56.4 50.0 35.1 42.7 27.8 8.4 15.5 35.5 106.5 58.3 114.5 57.7 12.0 15.4 72.5 19.3 3.8 9.5 7.9 6.9 4.3 1.1 0.9 32.0 41.6 2.1 5.5 6.8 3.3 2.4 3.7 7.5 4.5 1.6 9.6 3.1 3.6 0.6 10.3 1.0 5.0 0.4 1.9 3.3 2.3 18.4 1.7 12.2 17.2 50.6 2.4 18.4 4.0 1.8 5.0 2.5 43.7 5.6 6.4 3.0 4.3 0.4 20.2 0.7 4.7 0.6 8.5 3.7 12.6 0.4 1.1 2.5 6.3 1.3 1.8 4.4 9.8 2.7 4.2 1.5 7.5 1.5 32.2 43.3 4.8 3.8 3.7 1.6 23.9 14.9 15.0 9.5 15.6 7.7 11.2 8.0 9.5 15.4 12.0 9.2 8.7 72.5 3.8 19.3 11.8 9.2 7.9 7.7 40.3 7.5 26.2 28.8 7.9 10.9 2.3 47.7 8.4 390.1 865.0 231.9 792.8 1030.8 0.2 426.2 160.5 275.7 310.5 76.8 3.9 54.1 26.6 160.4 5.3 744.2 811.8 23.3 94.1 80.0 725.1 1061.8 658.8 174.2 657.2 1.6 607.3 243.7 446.3 5.2 516.4 1156.0 598.9 97.4 396.2 22.4 113.8 624.3 131.2 38.7 6.1 756.7 1665.5 1.2 3.3 1386.1 129.0 596.6 239.7 602.1 ZIK1 ZNF762 ENSG00000171649 "Zinc finger protein interacting with K protein 1" Q3SY52 19 57578456-57593777 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 16.7;NTERA-2: 20.0;REH: 14.3;U-266/84: 18.7" "Low region specificity" "Detected in all" HPA059975 Uncertain Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA059975: AB_2684184" "unprognostic (2.14e-2)" "unprognostic (9.03e-3)" "unprognostic (9.42e-2)" "unprognostic (1.83e-1)" "unprognostic (3.77e-2)" "unprognostic (1.34e-4)" "unprognostic (2.22e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-2)" "unprognostic (1.13e-1)" "unprognostic (8.16e-3)" "unprognostic (1.02e-1)" "unprognostic (4.18e-6)" "unprognostic (6.21e-2)" "unprognostic (5.15e-1)" "unprognostic (5.21e-2)" "unprognostic (3.50e-1)" 4.0 4.9 5.6 4.1 6.7 6.2 5.2 14.4 8.2 5.2 4.5 4.8 4.7 1.2 5.0 7.5 2.3 8.3 4.0 5.4 4.3 5.0 3.8 1.3 4.1 10.8 3.7 5.3 10.4 2.7 12.9 6.2 5.4 5.5 6.2 2.4 7.5 5.7 7.2 5.0 3.8 5.0 4.5 3.7 8.4 2.8 8.2 3.0 12.7 9.3 1.9 10.1 6.5 2.8 10.8 3.3 8.8 2.2 4.3 8.4 3.0 0.0 0.0 13.1 0.0 0.5 0.5 0.0 4.5 4.2 6.6 6.0 0.0 0.1 0.0 3.3 2.3 5.2 0.3 0.0 7.2 9.4 0.0 16.7 2.6 0.0 1.3 1.5 0.0 5.0 2.8 0.0 5.1 0.0 0.6 0.5 1.0 0.1 0.0 2.2 0.0 9.8 1.3 20.0 0.0 1.6 14.3 0.0 3.1 1.9 0.0 9.6 9.7 0.1 0.0 0.4 10.7 0.0 0.2 0.0 6.0 3.1 0.0 5.3 0.1 18.7 4.9 0.0 0.0 5.9 2.1 1.8 8.8 2.2 2.2 4.4 8.0 4.3 2.8 2.9 10.8 8.4 3.9 0.5 4.3 1.8 3.3 4.9 3.0 5.6 6.7 14.4 8.2 4.3 5.0 3.7 5.3 5.5 3.0 0.0 0.0 1.3 1.6 0.9 3.4 2.0 5.1 0.0 1.2 5.2 0.0 2.0 3.3 2.7 1.7 2.1 0.0 0.0 0.2 0.7 1.3 1.0 3.5 0.0 1.6 3.2 0.0 2.5 1.0 2.2 2.0 0.9 0.0 1.0 0.0 4.5 0.3 0.0 2.1 0.4 4.4 6.5 0.9 0.7 4.9 0.6 1.0 2.6 0.0 1.1 ZKSCAN5 "ZFP95, ZNF914, ZSCAN37" ENSG00000196652 "Zinc finger with KRAB and SCAN domains 5" Q9Y2L8 7 99504651-99534700 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003201 Uncertain Approved "Intermediate filaments" No No "Intermediate filaments" "HPA003201: AB_10610701" "unprognostic (2.47e-1)" "unprognostic (2.34e-2)" "unprognostic (2.99e-2)" "unprognostic (2.18e-1)" "unprognostic (4.42e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (7.59e-6)" "unprognostic (1.12e-1)" "unprognostic (2.15e-2)" "unprognostic (2.62e-1)" "unprognostic (5.35e-2)" "unprognostic (8.07e-2)" "unprognostic (1.18e-2)" "unprognostic (6.82e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (3.42e-1)" 6.3 7.2 8.4 5.9 11.8 5.4 8.1 16.5 12.6 7.2 6.1 12.9 3.8 3.7 7.7 8.4 5.4 7.6 5.9 7.4 9.8 8.2 7.4 6.6 6.8 6.7 9.9 8.2 8.9 7.6 10.5 9.0 7.7 9.8 7.6 6.4 6.8 4.7 8.8 9.5 5.2 5.3 9.9 7.2 6.9 5.5 17.8 10.2 12.5 8.7 4.6 8.6 7.3 5.8 1.7 4.0 4.7 2.8 3.8 4.7 2.4 5.6 9.5 11.4 15.1 8.5 6.3 4.6 9.8 10.0 12.1 11.9 6.5 5.3 9.7 9.3 7.6 14.8 4.1 10.5 6.9 12.3 5.8 5.0 6.1 6.4 6.1 8.6 9.1 10.3 5.6 9.6 10.5 16.2 7.7 8.6 8.9 12.9 13.6 13.0 7.2 13.0 10.0 9.8 5.2 7.7 8.0 10.1 8.2 7.6 5.7 8.0 13.0 9.3 8.1 7.1 9.7 5.0 7.0 7.7 15.3 11.1 12.2 8.3 9.1 12.9 15.2 6.8 6.2 13.6 1.3 1.5 4.7 4.7 2.8 4.1 1.7 1.7 2.3 4.0 0.9 3.5 3.7 0.3 3.8 1.7 1.6 2.9 2.4 8.4 11.8 16.5 12.6 9.8 8.2 9.9 8.2 9.8 10.2 6.0 2.7 7.1 1.6 2.4 5.4 5.0 0.0 1.4 6.8 3.5 13.7 2.9 0.0 2.6 3.9 3.5 3.8 0.0 2.9 2.8 3.4 2.0 5.7 3.0 2.8 9.5 5.8 5.5 3.5 1.6 3.7 3.9 0.0 2.8 2.7 8.1 3.8 0.0 5.3 2.1 6.3 6.5 3.1 10.9 5.9 2.5 2.2 3.5 2.3 0.9 ZNF189 ENSG00000136870 "Zinc finger protein 189" O75820 9 101398873-101410660 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 61.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034814 Uncertain Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA034814: AB_10601030" "unprognostic (3.87e-2)" "unprognostic (3.47e-1)" "unprognostic (5.30e-2)" "unprognostic (2.75e-1)" "unprognostic (6.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.26e-2)" "unprognostic (3.59e-3)" "unprognostic (1.70e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-1)" "unprognostic (1.10e-1)" "prognostic favorable (5.32e-4)" "unprognostic (3.31e-1)" "unprognostic (4.58e-1)" "unprognostic (1.86e-2)" "unprognostic (6.57e-2)" 15.6 15.8 15.1 6.3 28.2 2.8 11.6 13.9 15.9 9.5 9.0 16.8 9.0 8.6 10.0 61.6 5.5 7.8 16.3 10.9 18.7 9.3 10.6 12.5 6.8 6.8 15.4 11.4 11.8 23.0 11.2 23.6 6.3 14.1 10.3 7.5 5.0 6.7 9.4 11.6 4.4 9.7 9.7 25.1 9.9 8.7 9.3 16.1 8.5 9.6 3.7 10.2 6.1 8.0 3.6 2.2 4.1 3.0 3.6 4.7 1.9 5.5 4.6 15.0 10.9 13.5 9.5 7.2 8.0 12.3 9.4 8.2 9.7 4.4 7.5 5.4 9.6 9.9 10.9 7.5 7.6 8.4 9.9 5.2 8.2 7.2 20.6 10.1 8.5 7.2 11.5 10.5 8.3 13.0 12.9 11.6 9.2 9.7 10.9 13.8 3.1 10.2 3.7 10.8 12.3 5.2 7.3 21.5 5.7 8.9 6.5 15.6 9.8 8.6 6.0 8.6 10.3 4.9 10.9 9.7 9.2 6.7 7.6 6.1 10.4 16.0 3.6 8.0 3.4 9.3 1.3 2.5 4.1 2.3 3.0 2.4 2.8 4.0 4.7 2.2 3.6 4.7 4.1 1.4 3.6 2.3 1.7 2.0 1.9 15.1 28.2 13.9 15.9 18.7 9.3 15.4 11.4 14.1 16.1 8.9 5.4 2.4 7.4 8.8 7.9 20.2 22.9 8.1 12.5 1.8 3.9 3.6 8.3 5.3 1.9 9.0 4.9 0.0 15.9 1.7 8.0 5.2 9.2 7.8 4.7 7.9 5.2 8.0 14.0 1.5 10.3 6.6 6.8 1.8 5.3 6.7 8.4 4.9 10.3 11.4 3.3 12.9 9.2 6.2 3.4 5.6 1.6 5.4 3.6 3.5